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Worldwide, at least 200 million people are affected by peripheral vascular diseases (PVDs), 
including peripheral arterial disease (PAD), chronic venous insufficiency (CVI) and deep 
vein thrombosis (DVT). These diseases have considerable socioeconomic impacts due to 
their high prevalence, cost of investigation, treatment and their effects on quality of life. 
PVDs are often undiagnosed with up to 60% of patients with PVD remaining asymptomatic. 
Early diagnosis is essential for effective treatment and reducing socioeconomic costs, 
particularly in patients with diabetes where early endovascular treatment can prevent lower 
extremity amputation.  However, available diagnostic methods simply do not meet the needs 
of clinicians. For example, duplex ultrasound or plethysmography are time-consuming 
methods, costly and require access to highly trained clinicians. Due to the cost and time 
requirements of such methods, they are often reserved for symptomatic patients. On the other 
hand, the Ankle Brachial Index (ABI) test is cheap but has poor sensitivity for those patients 
with diabetes and the elderly, both growing high-risk populations.  
There is an urgent need for new diagnostic tools to enable earlier intervention. Researchers at 
the MARCS Institute have developed a novel hemodynamic monitor platform named HeMo, 
specifically for the assessment of peripheral blood flow in the leg. This development aimed to 
provide a fast and low-cost diagnosis of both peripheral arterial disease and chronic venous 
insufficiency. 
This work first provides a comprehensive literature review of the existing non-invasive 
diagnostic devices developed since 1677 to highlight the need of development of a new blood 
monitoring tool. Second, it presents the simplified circuit of the HeMo device and provides 
series of pilot experiments with HeMo demonstrating its potential for diagnosis of both 
peripheral arterial disease and chronic venous insufficiency. Third, it presents a quantitative 
 
 v 
characterisation of the electrical behaviour of the electro-resistive band sensors with the 
development of an expansion/contraction simulator rig and using spectral analysis. The 
characterisation of the electro-resistive band was essential to understand the nonlinear 
electrical behaviour of such sensors and would be of interest for other users and uses of the 
electro-resistive band sensors. However, in another perspective this sinusoidal linear 
stretching movement and the presented method shows an example for the application of the 
presented rig, highlighting that the same technique could be used for characterisation of 
similar stretchable sensors. Fourth, it shows data from a healthy population, assessing the 
performance of HeMo compared to light reflection rheography (LRR sensor-VasoScreen 
5000) for the assessment of venous function. Fifth, it presents human study data where the 
performance of HeMo is compared to photoplethysmography (PPG sensor-VasoScreen 5000) 
for the evaluation of the arterial function. Overall, the presented work here, steps toward 
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Chapter 1 Introduction 
This chapter provides an introduction to the research presented in this thesis. First, it provides 
detailed background information about Peripheral Vascular Diseases (PVDs) and the current 
relevant diagnostic modalities. It then, discusses the motivation for pursuing the development 
of a new non-invasive diagnostic tool for PVDs, and introduces the fundamental idea of a 
new hemodynamic monitoring device, which provides the foundation upon which this thesis 
is built. Then, an overview of the undertaken research is presented along with a summary of 
thesis contributions and a list of publications resulting from this thesis. Finally, the thesis 
structure is presented.  
Some of the work presented in this chapter has been published in: 
“Shabani Varaki E, Gargiulo GD, Penkala S, Breen PP. Peripheral vascular disease 
assessment in the lower limb: a review of current and emerging non-invasive diagnostic 
methods. Biomed Eng Online. BioMed Central; 2018; 17:61.” 
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1.1 Literature Review 
1.1.1 Peripheral Vascular Diseases 
Peripheral vascular disease (PVD) is a major cause of morbidity and mortality, with 
significant financial burdens on critical healthcare resources [1–10]. Vascular diseases result 
from circulatory system dysfunction caused by damage, occlusion and/or inflammation of 
arteries and/or veins [11]. Peripheral Arterial Disease (PAD), Chronic Venous Disease 
(CVD), which includes Chronic Venous Insufficiency (CVI) and Deep Vein Thrombosis 
(DVT), are common types of PVDs and are the most prevalent in the lower extremities. 
Peripheral arterial disease is typically the result of the build-up of plaque (substances in the 
blood such as fat or calcium) in the arteries. This mass of plaque gradually narrows the 
arteries and impedes the flow of blood. The body segment supplied by the blocked or 
narrowed artery is then deprived of oxygen-rich blood [12], often resulting in pain and 
numbness [13]. This blockage can increase the risk of infection in the affected area, while 
severe blockage of blood flow can lead to gangrene (tissue death) and ultimately amputation 
[14,15]. In addition, PAD increases the risk of severe medical events such as coronary heart 
disease, heart attack, and stroke [2,13]. PAD affects 10–15% of the general population and 
about 20% of people aged over 60 years [2], [16]. Worldwide, the incidence of PAD has 
increased from 164 million in 2000 to 202 million in 2010 [17]. 
Another common type of peripheral vascular disease is Chronic Venous Insufficiency (CVI), 
also known as post thrombotic syndrome [18,19]. When standing upright, the blood in the leg 
veins must move against the force of gravity in order to return to the heart [20]. This venous 
return is achieved through active compression of the lower limb veins via contraction of 
muscles of the feet and legs [20]. Retrograde flow is prevented by a system of one-way 
valves in the veins [20]. However, extended periods of sitting or standing can lead to pooling 
of blood and an increase in venous blood pressure in the lower limb. Although leg veins are 
usually able to tolerate increased blood pressure over short periods of time, extended periods 
of increased venous pressure can lead to stretched vein walls and damaged venous valves, 
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ultimately leading to CVI [20,21]. CVI symptoms range from a vague feeling of heaviness in 
lower extremities, swelling of the legs, aching, itching, skin colour changes and ulceration 
[20]. The overall prognosis of such ulceration is poor, with delayed healing and recurrent 
ulceration [7,8]. More than half of venous ulcerations require long duration therapy lasting 
more than one year [8,22]. Disability caused by venous ulceration leads to loss of productive 
work hours (estimated at 2 million workdays/year) and early retirement [8,23]. In addition, 
the financial burden of venous ulceration to the healthcare systems in western countries is 
reported to be more than $3 billion annually [3,8]. 
Deep Vein Thrombosis (DVT) is the formation of a blood clot in a vein deep in the body, 
commonly in the lower limbs [24]. Although the presence of a DVT is not necessarily 
symptomatic, some patients with DVT suffer from leg pain, swelling, tenderness and redness 
of the affected area [24]–[26]. The most serious consequence of DVT is a condition known as 
pulmonary embolism which occurs when blood clots break off and travel through the 
bloodstream to arteries of the lungs leading to partially/completely block of blood flow, 
ultimately leading to disability or death [24,25]. Population studies have estimated annual 
incidence of DVT as 0.5-1 per 1000 in general population [6,24–26]. Approximately one 
third of patients with DVT may develop a pulmonary embolism of whom about 20% of 
patients die before diagnosis or on the first day of diagnosis [25,27]. 
Early diagnosis and management of PVD is crucial to address the high rates of mortality and 
morbidity, however around 50% of people are asymptomatic and therefore do not necessary 
seek medical assistance, or are not screened by clinicians in the absence of diagnosed disease.  
Establishing effective and efficient clinical non-invasive diagnostic tools to determine 
vascular competence is essential particularly for asymptomatic PVD patients who have the 
same risk of morbidity and mortality as those with more obvious symptoms [2,28,29]. Given 
the prevalence and socioeconomic impacts of PVDs, a variety of both invasive and non-
invasive diagnostic devices have been developed since the 1670s to facilitate accurate 
diagnosis and address the prevalence and socioeconomic impacts of PVDs [30,31].  
Here, a comprehensive literature review of the available non-invasive methods for the 
assessment of peripheral hemodynamic function in the lower extremities is presented to 
provide background information in regards with the area of PVD diagnosis and to 
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demonstrate the importance of the research question of this thesis. Note that this review is not 
a systematic review but it is a narrative review, which focuses on a comprehensive critical 
analysis of the existing knowledge on the topic of interest. Such a review provides a 
theoretical framework, which can pinpoint trends, and provide information both on the needs 
and inconsistencies in the research. This could ultimately lead to greater definition of a 
research question and justify the research being undertaken. 
First, the invasive PVD diagnostic methods are briefly examined to emphasize the 
importance of non-invasive diagnosis. Subsequently, three primary validated non-invasive 
technologies (Plethysmography, Doppler Ultrasound and Blood Pressure methods) are 
discussed in detail. Then, emerging diagnostic techniques are presented. Finally, the 
limitations and strengths of each method are identified to clarify the motivation behind this 
research. 
1.1.2 Invasive methods 
The existing tools for peripheral vascular disease diagnosis can be divided into invasive and 
non-invasive methods. In this section, the three primary invasive methods, Angiography, 
Venography and Ambulatory Venous Pressure are briefly reviewed. 
Angiography 
Angiography, also known as Arteriography, is an imaging technique used to visualize inside 
blood vessels. With this method, a radio-opaque contrast agent is injected into the blood 
vessel and imaging techniques are used to provide information about blood vessel 
abnormalities such as narrowing, blockage, inflammation, abnormal widening and bleeding. 
A variety of angiography methods exist for the assessment of PAD [32]. Traditional 
angiography uses X-ray based imaging techniques while computed tomography angiography 
requires exposure to ionizing radiation and the injection of relatively large volume of contrast 
agent [33]. Magnetic resonance angiography is a less invasive method, but has limited spatial 
resolution, leading to reduced sensitivity. In addition to the invasive nature of the 
angiography test itself, there are risks and complications which may occur following the test 
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procedure such as seizures, haemorrhage (bleeding), arterial obstruction, nephrotoxicity 
(kidney poisoning) and acute impairment of renal function [34–36]. 
Venography 
Venography, also known as Phlebography, involves the insertion of a catheter into a foot vein 
and subsequent injection of a contrast dye. A venogram (X-ray of veins) is taken to examine 
the functionality of the valves in the deep veins. Although this method is still used for 
planning treatment, it is rarely performed due to the high associated cost and attendant risks. 
Venography can cause cellulitis with the potential for the development of tissue ulceration, 
necrosis (death of cells) and gangrene (death of tissue) [37]. Other complications include 
development of thrombosis after the venography procedure (reported in up to 13% of 
patients) [37]. 
Ambulatory Venous Pressure 
Ambulatory Venous Pressure is measured by placing a 21-gauge needle into a dorsal foot 
vein and connecting it to a pressure transducer [37]. The procedure typically involves an 
initial measure of venous pressure with the patient in the standing position. The patient is 
then asked to perform tiptoe exercises while the venous pressure is recorded. Finally, the 
patient is asked to stand at rest, while the rate at which venous pressure returns to the initial 
resting value is measured. The change of venous pressure is monitored as an indication of 
vascular system health. Venous ambulatory pressure measurement requires specialist 
clinicians, and similar to angiography and venography is not suitable for routine screening or 
monitoring the progression of therapy due to its invasive nature [37,38]. 
Although the invasive methods are highly accurate, they are expensive, uncomfortable for 
patients and carry inherent risks. These methods are typically reserved for instances where 
highly detailed measurements are required, for example, before surgical planning. However, 
the level of risk and discomfort is not appropriate for routine screening, but which is crucial 
for early disease diagnosis when preventative care could have the greatest benefit. Non-
invasive methods are an alternative and can be used more routinely for diagnosis and follow-
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up of subsequent treatment. However, each method has limitations, which continue to 
motivate the development of new diagnostic and clinically applied methods. 
1.1.3 Non-invasive Plethysmographic Methods 
Plethysmography measures blood volume changes in the lower extremities. The principle of 
plethysmography for limb volume measurement was first introduced by Francis Glissonioin 
in 1677 using water displacement [30,31]. Later, the classic water plethysmography method 
was modified to other measures of volume (i.e. strain gauge, photo, impedance and air) to 
reduce the complexity of the measurement and improve accuracy [30]. Using 
plethysmographic devices, information such as the venous filling index (VFI), ejection 
fraction, residual volume fraction (RVF) and arterial pulse wave shape can be determined and 
used to evaluate peripheral vascular function [39,40]. Strain gauge, photo, impedance, and air 
plethysmography are discussed further in the following sections. Figure 1.1 represents an 




Figure 1. 1. Examples of peripheral vascular function assessment in the lower limb using plethysmography 
techniques; (a) Strain Gauge Plethysmography [41]; (b) Photo Plethysmography (PPG); (c) quantitative 
PPG/Light Reflection Rheography (LRR); (d) Impedance Plethysmography [42]; (e) Air Plethysmography [43]. 
Strain Gauge Plethysmography (SGP) 
Strain Gauge Plethysmography (SGP) was first introduced in 1953 and later improved in the 
1990s [30,44–46]. SGP can be used to assess both the peripheral arterial and venous systems. 
The flexible strain gauge is filled with a conductive medium, usually mercury or gallium, and 
fit snugly around the limb (Figure 1.1a) [31]. Changes in limb blood volume is estimated 
from proportional changes in the electrical impedance of the strain gauge [31]. 
SGP reliability has been questioned because of the lack of validation studies [31]. Reference 
values for computerized SGP were provided in a 2014 study based on data from 63 healthy 
controls and 56 patients with DVT and post-thrombotic changes [46]. Table 1.1 represents 
the mean and 95% confidence interval reference values for each variable (venous emptying, 
venous outflow rate, half refilling time and venous refilling volume) derived from the control 
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and patient with DVT cohorts [46]. Venous emptying was defined as the blood volume 
reduction during the first second following cuff release. Venous outflow rate was defined as 
the expelled volume during the first 4 seconds following cuff release divided by the 
maximum venous volume and half refilling time referred to the time required for a 50% post 
exercise volume refilling [45,46]. A right/left side difference of 5-10% was found to be 
normal for venous emptying and venous outflow rate. A 20-25% side difference for venous 
refilling volume and venous refilling time was also determined to be normal [46]. However, a 
reduction in venous emptying and venous outflow rate beyond these inferred a functional 
outflow obstruction, i.e. the presence of DVT [46]. 
Parameters indicative of DVT detection (venous emptying and venous outflow rate), muscle 
pump function (venous refilling volume), and the presence/absence of venous reflux (half 
refilling time) were tested for disease sensitivity [46]. Combined, these measures had an 
overall sensitivity of 96% to broadly detect a venous disorder, without the sensitivity to 
specifically identify the particular component (i.e. the presence of venous reflux and/or DVT)  
Table 1. 1. Computerized strain-gauge plethysmography reference values for controls and patients with DVT 
(from [46]). 
Venous Parameter Control  (mean and 95% 
confidence interval) 
Patients with DVT (mean and 
95% confidence interval) 
Venous emptying (mL/100mL×min) 84 (78-90) 110 (104-116) 
Venous outflow rate 0.58 (0.54-0.62) 0.76 (0.74-0.78) 
Half refilling time (Seconds) 6 (4-7) 17 (15-18) 
Venous refilling volume (mL/100mL) 1.11 (0.95-1.27) 1.65 (1.52-1.78) 
 
[46]. From these results, it is not possible to determine the accuracy of diagnosing specific 
venous disorders via strain gauge plethysmography. Other limitations that need to be 
considered with strain gauge plethysmography include temperature sensitivity and chemical 




Photo Plethysmography (PPG) 
Photo Plethysmography (PPG), first introduced in the 1930’s to assess the vascular system, 
uses an infrared light source and a light receptor to estimate the variation of blood volume 
[48]. There are two common PPG sensor designs; one in which the toe or finger is placed 
between a light source and a light receptor, commonly known as PPG (Figure 1.1b); in the 
second configuration, known as quantitative PPG or Light Reflection Rheography (LRR) 
(Figure 1.1c), the light source and receptor are placed beside each other [31]. PPG produces a 
pulsatile waveform (AC) superimposed on a slowly changing baseline (DC) [49]. The AC 
component is used to measure changes in the blood volume due to arterial pulsation, and the 
DC component changes in total blood volume [31,49,50]. The derived arterial pulse wave 
enables the diagnosis of arterial incompetence [31]. Venous refilling time can also be 
measured by calculating changes in blood volume between static positioning and post-
exercise (usually ten dorsiflexion manoeuvres) [31]. Venous refilling time is the time taken 
for the PPG curve to return to a stable value for at least five seconds [51]. Table 1.2 provides 
a summary of the sensitivity and specificity values calculated from evaluations of PPG for the 
diagnosis of PVDs. 
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A study of 63 healthy subjects and 44 PAD patients compared PPG derived pulse wave 
analysis techniques extracted timing, amplitude and shape characteristics for both toes and 
for right-to-left toe differences and compared these to diagnosis using the Ankle Brachial 
Index (Table 1.2). Sensitivity of 90.6%, specificity of 88.9% and accuracy of 90.2% was 
reported [52]. In a later study, comparing PPG to angiography, a reduced sensitivity (81.6%) 
and specificity (77.4%) was reported in a cohort of 97 patients (194 legs; Table 1.2) [53]. In 
this study, a physician visually interpreted the average of PPG waveform during at least 60 
heartbeats to diagnose PAD. Qualitative evaluation of the PPG waveform and greater 
precision of angiography over ABI may account for the lower reported specificity and 
sensitivity values [2,60,61]. 
PPG has also been used to evaluate venous reflux, with a reported sensitivity of 100% and 
specificity of 60%, in a relatively small study of 10 healthy subjects and 10 subjects with 
deep venous reflux diagnosed using duplex ultrasonography [54]. The venous refill time was 
calculated following five dorsiflexion manoeuvres with the leg in a dependent position while 
sitting [54]. The mean venous refill time for the healthy group was 20.2 ± 1.1 seconds and 6.4 
± 8.9 seconds in the patient group [54]. A threshold venous refill time greater than 20 seconds 
was considered normal, In a larger study of 152 patients (304 legs) using the 20 second 
venous refill threshold; lower sensitivity 74% (superficial reflux), 79% (deep venous reflux) 
and specificity (61%) was reported [55].  
Examinations of the clinical utility of PPG in the diagnosis of Deep Vein Thrombosis (DVT) 
have reported sensitivity between 83 and 100% and specificity between 35 and 89% (Table 
1.2) [48-51]. In a study of 69 patients with suspected DVT, PPG using LRR was compared 





“*” denotes the number of the limbs used in the study and not the number of subjects. 
“Control” refers to the number of the subjects diagnosed without PVD by the reference method 
“Patient” refers to the number of the subjects diagnosed with PVD by the reference method. 
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exercises [56]. A venous emptying threshold (ΔR) of ≤ 3mm (measured from the LRR 
tracing) resulted in sensitivity of 96% and specificity of 71% for detecting a DVT. Increasing 
the ΔR threshold to ≤ 6mm reduced sensitivity to 86% and increased specificity to 89% [56]. 
Alternatively, using the venous emptying rate to diagnose DVT, a threshold of 
0.17mm/second produced sensitivity of 83% and specificity of 89% [56]. Increasing the 
threshold to 0.31 mm/second, a sensitivity of 96% and a specificity of 78% was achieved 
[56]. Similarly, in a study of 69 limbs a threshold value of 0.35mm/second for the venous 
emptying rate, provided a sensitivity of 96.4% and a specificity of 82.9% [57]. Furthermore, 
the performance of LRR, in comparison to either venography or duplex imaging, in a study of 
103 legs with a suspected DVT provided high sensitivity but without high specificity [59]. 
This study evaluated venous refilling time and venous pump function, defined as the 
amplitude of the LRR trace during dorsiflexion contraction [59]. A venous refilling time 
threshold of ≤ 20 seconds returned sensitivity of 100% and specificity of 47%. Increasing this 
threshold to ≤ 36 seconds, sensitivity remained the same but specificity reduced to 35%. The 
combined specificity of venous refilling time and the venous pump was still quite low at 56% 
[59]. These measures of venous refilling time and venous pump function progressively 
decrease with age, further leading to less distinction between normal and abnormal groups 
[59]. 
Thomas et al. used a different criterion for assessing the performance of LRR versus 
venography in a group of 131 legs with clinically suspected DVT, classifying a DVT by a flat 
or a virtually flat LRR trace [58]. Using the shape of the LRR trace as the diagnostic criteria, 
they achieved a sensitivity of 92% and a specificity of 84% [58]. They reported that false 
negatives or positives only occurred for patients aged ≥  55 years, suggesting that LRR may 
not be a good screening tool in the elderly [58].  
Impedance Plethysmography (IPG) 
In 1939, Nyboer introduced the concept of impedance plethysmography (IPG), and in the 
1970’s several IPG devices became commercially available particularly for the diagnosis of 
PVDs [62,63]. IPG uses electrical impedance to derive changes in blood volume to determine 
hemodynamic functionality. In this method, circumferential electrodes are placed on the leg 
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(Figure 1.1d), a weak high-frequency alternating current passes through the leg, and voltage 
changes in the electrodes are monitored to measure blood volume changes in the test area 
[31]. This plethysmography method is reported to be less cumbersome than fluid 
displacement based plethysmographic methods [53, 54]. Additionally, as discussed in the 
following paragraphs, IPG can be employed to detect DVT and to evaluate both arterial and 
venous competence [63–65]. 
In a study of 33 legs with arteriography confirmed arterial obstruction greater than 50% 
diameter, compared to 28 healthy control legs, IPG waveform analysis (resting arterial pulse 
wave amplitude and maximum systolic slope) provided a sensitivity and specificity greater 
than 90% [63]. Threshold pulse wave amplitude of 0.06%dR (resistance change due to blood 
volume change) and 0.60%dR/sec for systolic slope were used [63]. When compared to ABI 
diagnosed PVD in a study of 66 patients, a sensitivity of 73.2% and a specificity of 96% was 
reported, using crest time thresholds of 180ms [66]. 
Anderson evaluated IPG for detecting CVI in 44 subjects compared to Doppler ultrasound 
[40]. Venous refilling time >11 seconds was chosen to represent a competent set of venous 
valves, while <11 seconds indicated venous reflux [40]. Reported accuracy was 90%, 
however, sensitivity and specificity values were not provided [40]. 
IPG to detect the presence of DVT evaluates the patient in supine position with the leg 
elevated above the level of the heart (Figure 1.2). A thigh cuff is inflated above venous 
pressure (50mmHg) with calf impedance monitored until plateau before cuff deflation. The 
presence of DVT is inferred by measuring maximum venous capacitance (venous volume 
after 50mmHg pressure application) and venous outflow rate (venous volume decrease in the 
first 3 seconds of deflation) [63,67]. Six medical centres were cited to independently confirm 
the accuracy (>94%) of IPG to diagnose a recent DVT proximal to the knee [63]. Sinton et al. 
compared IPG with venography in 85 legs and reported that IPG was successful in detecting 
proximal DVT in 20 of 22 subjects [68]. However, IPG was less successful in distinguishing 
been healthy and pathological groups for distal DVT’s [68]. A review of venous disorder 
diagnosis reported acceptable sensitivity (87–98%) for IPG compared to venography [67,69–





Figure 1. 2. Schematic view of the use of impedance plethysmography for detection of DVT (adapted from 
[63]). 
Air Plethysmography (APG) 
Air Plethysmography (APG) was first introduced by Christopoulos et al. in 1987 for 
evaluation of venous function in the lower extremities [79,80]. An air-filled chamber encloses 
the lower limb and air displacement is used to measure blood volume changes (Figure 1.1e). 
The Venous Filling Index (VFI) measurement involves the patient elevating their leg in the 
supine position, allowing the leg to empty, and then resuming the standing position. The VFI 
is defined as 90% of the venous volume at rest divided by the time taken for 90% venous 
refilling following the leg elevation manoeuvrer [80]. VFI has been reported to be predictive 
of venous reflux, with a VFI less than 2 ml/sec demonstrated no reflux, legs with VFI of 2-7 
ml/sec demonstrated reflux to above the knee, and a VFI higher than 7 represented venous 
reflux to below the knee [79]. A VFI threshold greater than 7 had sensitivity of 73%, 
specificity of 100%, and accuracy of 81% when compared to phlebography for diagnosing 
venous reflux in 31 limbs [79].  
In a study of 186 extremities, APG derived VFI demonstrated sensitivity of 80% and 
specificity of ~94% for detecting venous reflux when compared to venography and duplex 
scanning results [39]. The investigators also calculated residual volume fractions - difference 
between venous volume in the leg elevation position and following ten heel raise exercises, 















residual volume fraction can increase the specificity from 90% to 100% compared to VFI 
[54]. While residual volume fractions can increase specificity, it is not very helpful clinically 
as only a small subset of patients with symptomatic venous insufficiency have a normal VFI 
[39]. Due to the relative ease-of-use and reproducibility of APG, it has replaced strain-gauge 
plethysmography and photo-plethysmography in CVI diagnosis [79]. 
APG can also be used to detect the presence of venous occlusion. Venous obstruction affects 
the relationship between venous volume and pressure [79,82]. Harada et al. used APG to 
measure residual volume fraction and compared it with ambulatory venous pressure [79]. A 
high correlation (r=0.86) between these two factors was found when no venous obstruction 
was present, while a poor correlation (r=0.40) indicated venous occlusion [79]. However, in 
terms of clinical utility, the measurement of ambulatory pressure is an invasive and 
uncomfortable procedure, making this diagnostic unsuitable for routine use. 
Summary and Limitations of Plethysmographic Methods 
Several plethysmography methods have been developed since 1677 for the assessment of 
peripheral vascular function noninvasively. The oldest plethysmography method, water 
plethysmography, has been used mostly in clinical research rather than in medical practice, as 
it is cumbersome to use and difficult to calibrate [31]. Later, strain gauge and photo 
plethysmography were introduced. Strain gauge plethysmography lacks validation studies 
[31], is sensitive to temperature variations, and the use of mercury gauges have 
environmental pollution concerns [47]. On the other hand, while photo plethysmography has 
acceptable sensitivity and specificity for arterial disease, it has low sensitivity and specificity 
when detecting venous reflux [55], which further decreases in elderly populations [58]. 
Impedance plethysmography and air plethysmography were developed later. However, 
impedance plethysmography has shown to have low sensitivity (12% to 64%) for detecting 
asymptomatic DVTs [67] and air plethysmography has a relatively low sensitivity (73%) in 
detecting venous reflux [79].  Additionally, air plethysmography requires associated use of 
invasive ambulatory venous pressure measurement for diagnosis of venous occlusion. 
Therefore, although air plethysmography has been reported to have more reproducibility than 
strain-gauge plethysmography and photo-plethysmography [79], it is not the most popular 
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technique for peripheral vascular assessment. Photo-plethysmography is generally most 
popular, however, plethysmography remains cumbersome, requires careful setup by a trained 
practitioner, and takes considerable time to perform the assessment [14]. While 
plethysmographic methods have considerable utility in functional assessment, these time and 
personnel requirements have meant that they have been largely replaced by Doppler 
ultrasound methods, which will be discussed in the next section [31]. [31]. Table 1.3 
demonstrates a summary of the discussed plethysmography studies. 
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Allen et al. 
[52] 
PAD ABI 107 (63/44) PPG 90.6%, 88.9% 
Ro et al. [53] PAD Angiography 
194* 
(31/163) 
PPG 81.6% 77.4% 





20* (10/10) PPG 100% 60% 







PPG 74-79% 61% 
Mitrani et al. 
[56] 
DVT Venography 69 (45/24) PPG 83%-96% 71%-89% 
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Arora et al. 
[57] 
DVT Venography 69* (41/28) PPG 96.4% 82.9% 
Thomas et al. 
[58] 
DVT Venography 131* (61/70) PPG 92% 84% 







PPG 100% 35%-56% 
Anderson 
[40] 
PAD Angiography 61* (28/33) IPG >90% >90% 
Mašanauskie
nė et al. [66] 
PAD ABI 62 (21/41) IPG 73.2% 96% 
Hull et al. 
[69] 
DVT Venography 200 (114/86) IPG 94% 91% 
Toy et al. 
[70] 






IPG 90.4% 75.7% 
Cooperman 
et al. [72]   
DVT Venography 98* (75/23) IPG 87% 96% 





IPG 91% 89% 
Peters et al. 
[74] 
DVT Venography 185(124/61) IPG 84% 93% 
Cruickshank 










IPG 12.3% 99.1% 





IPG 19% 91% 
“*” denotes the number of the limbs used in the study and not the number of subjects. 
“Control” refers to the number of the subjects diagnosed without PVD by the reference method 
“Patient” refers to the number of the subjects diagnosed with PVD by the reference method. 
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1.1.4 Non-invasive Ultrasound Methods 
Vascular ultrasonography is a non-invasive diagnostic method utilizing a handheld transducer 
to direct an inaudible sound wave with a frequency of 1-30MHz into the vessel of interest to 
assess vascular competency [83]. Computer processing converts the data to audible sound 
waves or graphs, allowing the vascular technician to see and/or hear blood flow through the 
vessels and is the mainstay of vascular imaging. B-mode, Continuous Wave, Pulsed wave 
Doppler and Duplex Ultrasound are used to assess the vascular system [28,83–86]. 
B-mode Doppler Ultrasound 
B-mode (brightness mode) ultrasonography or grey-scale imaging generates a two 
dimensional real-time picture to visualize the structure of blood vessels and provides 
information about diameter change in large veins [54,84,87,88]. 
Dauzat et al. evaluated the clinical value of B-mode for DVT detection in a group of 145 
patients and reported a sensitivity of 94% and a specificity of 100% compared to venography 
[89]. O’Leary et al also used B-mode and found a sensitivity of 88% and a specificity of 96% 
to detect DVT in 50 subjects compared to venography results [90]. In another study, Sullivan 
et al. compared B-mode ultrasound with venography for detection of DVT in 23 patients and 
found a sensitivity of 100% and a specificity of 92% [91]. They also compared the results of 
B-mode and rheography for detection of DVT in 170 extremities and found an agreement of 
82% between the two methods [91]. This study also reported the capability of B-mode in 
distinguishing an acute DVT from a chronic DVT in 93% of the extremities which underwent 
venography [91].  
Continuous Wave (CW) Doppler Ultrasound 
Continuous Wave (CW) Doppler Ultrasound is routinely used for clinical screening. Venous 
flow is heard as a low-pitched blowing sound and a normal venous blood flow should be in 
phase with respiration [83,85]. If manual limb compression is applied distal to the probe, the 
forward flow (flow towards the heart) will be augmented. The augmentation can be seen as 
an increase in the amplitude of the CW Doppler signal [83]. If limb compression is applied 
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proximal to the probe, and valves are competent, the Doppler signal should cease as healthy 
valves limit retrograde flow [83]. A similar decrease in the blood flow signal can be noted 
when the patient coughs or performs a Valsalva manoeuvre [83]. Venous reflux can thus de 
diagnosed by an audible signal during the compression or Valsalva manoeuvre. If the signal 
lasts for more than 5 seconds, venous reflux is inferred [83,87]. 
Pulsed Wave (PW) Doppler Ultrasound 
Pulsed Wave Doppler mode can be used for categorizing peripheral arterial stenosis [86]. 
Although PW Doppler overcomes the limitation of CW Doppler in depth discrimination, it is 
unable to measure high velocities due to the aliasing phenomenon [92]. Aliasing occurs when 
the velocity of blood flow exceeds one half of the pulse repetition frequency (usually a 
velocity above 2m/sec) and it affects the velocity waveform such that the velocity and 
direction of blood flow cannot be interpreted [92]. 
Duplex Ultrasound (DU) 
Duplex ultrasound combines the use of B-mode imaging, PW, CW Doppler modes when 
evaluation of the anatomy and hemodynamic function of the vascular system is needed [28]. 
Duplex ultrasound thus is a very sensitive diagnostic method [87], and can be used for 
detecting venous reflux, arterial stenosis/occlusion and deep vein thrombosis. In one study, 
169 limbs were evaluated using duplex ultrasound for diagnosing peripheral arterial disease 
[34]. Patients rested for 15 minutes before examination. Subsequently, both lower limbs were 
scanned from the common femoral artery to the pedal arteries and the entire limb was divided 
into 15 segments [34]. Arterial occlusion was determined by observation of a dampened 
distal signal in comparison with the proximal signal; presence of a proximal exit collateral; 
and presence of a distal re-entry collateral. Peak systolic velocity ratio (the peak systolic 
velocity in the stenosis divided by the peak systolic velocity just proximal to the stenosis) 
was also measured for those segments with flow velocity increase [34]. Segments with a peak 
systolic velocity ratio ≥ 2m/sec inferred a diameter reduction ≥ 50% [34]. Duplex ultrasound 
was reported to have a sensitivity of 88%, specificity of 79% and accuracy of 95% among 
2535 segments (169 limbs × 15 segments) when compared to angiography (Table 1.4) [34]. 
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In another study of 100 subjects, greater sensitivity 95% and 92% and specificity (99% and 
97%) were reported for the diagnosis of arterial occlusion and stenosis respectively when 
compared to angiography [28,93]. A review of Duplex ultrasound performance for the 
diagnosis of PAD found the sensitivity values between the range of 79.7%-97% and the 
specificity ranged from 88.5% to 99% in comparison to angiography [32,94–96]. It also 
suggested that segment-to-segment comparison possibly increases the number of true 
negative test results leading to an overestimation of the specificity [32].  
Duplex ultrasound is arguably the most important and widely used non-invasive tool for the 
investigation of chronic venous diseases [97]. It can detect minimal venous reflux even in 
isolated veins of asymptomatic individuals [87]. Duplex scanning can also determine if the 
reflux is constrained in veins above or below the knee [87], a limitation of the previously 
reported IPG diagnosis of venous reflux. Duplex ultrasound scanning is undertaken with the 
patient in the standing position to allow maximum venous dilation [98]. Several manoeuvres 
such as foot/calf compression, ankle dorsiflexion and Valsalva can be performed to create 
physiologic flow [97]. Alternately the patient may be placed in a 15° reversed trendelenburg 
position and then asked to perform a Valsalva manoeuvre [87]. Nicolaides argued that both of 
these examination lead to similar results, and while the second method is more convenient, it 
does require cooperation from the patient [87]. A reversal of flow during the diagnostic 
manoeuvres infers venous reflux [97]. Threshold values for the diagnosis of venous reflux are 
defined as retrograde flow lasting longer than 1000ms in the femoral area or longer than 
500ms in the femoral and popliteal veins [98]. 
At the beginning of the 21st century, the use of duplex ultrasound was extended to detect 
venous obstruction and its extent [87]. Continuous flow in the femoral veins with little or no 
change in flow during any manoeuvre infers abnormality [98]. However, the presence of 
phasic flow does not exclude the potential presence of an obstruction and repeat scans are 
recommended to confirm or exclude DVT [98]. While duplex ultrasound can detect the 
presence of venous stenosis by measuring luminal reduction the extent of occlusion is better 
evaluated with magnetic resonance venography, computed tomography venography or 
contrast venography [98]. Cronan et al. compared the performance of Duplex ultrasound for 
detection of DVT in 51 subjects and found 89% sensitivity and 100% specificity [99]. In a 
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systematic review of diagnostic accuracy of ultrasound for DVT, sensitivity of Duplex 
ultrasound ranged from 75-96%, and a specificity of 94% depending on the site of DVT 
[100]. 
Colour Duplex imaging can also be used to evaluate the direction and velocity of blood flow 
and thus detect the location of arterial occlusion/stenosis and venous reflux [28,86,101,102]. 
A study compared colour Doppler imaging with angiography for detection of occlusion and 
stenosis in one hundred legs of 51 patients [93]. Occlusion detection had a sensitivity of 95% 
and specificity of 99%, while stenosis detection had sensitivity of 92% and a specificity of 
97% [93]. Examination time of 30-45 minutes was reported for each patient [93]. In general, 
colour Duplex imaging provides better accuracy [101]. However, Doppler transducer 
positioning (70° to the vessel) is critical and requires highly trained and experienced 
operators [103]. 
Summary and Limitations of Ultrasound Methods 
Vascular ultrasonography is one of the most commonly used non-invasive methods employed 
by vascular laboratories to define anatomy, hemodynamic and lesion morphology. Ultrasound 
examination is considered to be the gold standard and a very powerful tool in establishing 
diagnosis and aiding therapeutic management of chronic venous insufficiency and peripheral 
arterial disease, revealing sites of reflux and/or obstruction in the venous system, arterial 
occlusions and stenosis [98]. However, the use of duplex ultrasound is highly operator 
dependent [34,87]. Furthermore, 5-20% of patients cannot undergo duplex ultrasound wave 
exposure because of ulceration, pain, swelling, heavily calcified arteries and obesity [34]. 
Moreover, duplex ultrasonography can be time-consuming (1-2 hours for full assessment), 
requires expensive equipment and a highly trained, experienced vascular technician with 
comprehensive knowledge of the anatomy of the vascular system [97]. Lack of a universally 
accepted protocols for detection of DVT using the ultrasonic methods is an additional issue 
[104].These factors therefore limit the use of ultrasound for routine examination and early 
diagnosis of PVDs. 
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Dauzat et al. 
[89] 
DVT Venography 145 (45/100) B-mode 94% 100% 
Sullivan et al. 
[91] 
DVT Venography 23*(12/11) B-mode 100% 92% 
O’Leary et 
al. [90] 
DVT Venography 50 (25/25) B-mode 88% 96% 
Cronan et al. 
[99] 
DVT Venography 51(23/28) Duplex 89% 100% 
Aly et al. 
[95] 
PAD Angiography 177*† Duplex 92% 99% 
Linke et al. 
[94] 
PAD Angiography 46*† Duplex 89% 95% 
Bergamini et 
al. [96] 
PAD Angiography 80*(28/52) Duplex 80% 95% 
Eiberg et al. 
[34] 
PAD Angiography 169 (0/169)  Duplex 88% 79% 




Angiography 51 (8/43) Duplex 95% 99% 




Angiography 51 (8/43) Duplex 92% 97% 
“*” denotes the number of the limbs used in the study and not the number of subjects. 
“†” comparison between limb segments and not control/patients. 
“Control” refers to the number of the subjects diagnosed without PVD by the reference method 
“Patient” refers to the number of the subjects diagnosed with PVD by the reference method. 
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1.1.5 Non-invasive Blood Pressure Methods  
Ankle Brachial Index (ABI) 
In the 1950’s, Winsor first described the Ankle Brachial Index (ABI), a simple non-invasive 
method for assessing arterial perfusion [105]. It remains a primary clinical diagnostic test for 
PAD [106]. The ABI is measured by calculating the blood pressure at the ankle and dividing 
by the higher of two brachial systolic blood pressures [28,105]. A normal ABI is between 1 
and 1.3 [107] with 0.91 to 0.99 acceptable [106]. An ABI lower than 0.9 indicates the 
presence of PAD with ratios below 0.4 indicating the presence of severe PAD and problems 
for healing [28,108]. While an ABI between 0.91 and 0.99 is acceptable, this range and below 
also indicates increased cardiovascular risk [108], including stroke, coronary diseases or 
cardiovascular death [109–111]. ABI has a relatively high sensitivity and specificity, but such 
high accuracy cannot be achieved for all patient types. Arteries of the elderly, patients with 
diabetes or renal disease are usually calcified and largely incompressible, leading to poor 
sensitivity in such cases [28]. The poor sensitivity of ABI has been referenced in studies 
where the ABI appeared to be normal (1-1.3) or even supernormal (above 1.3) for a group of 
patients with PAD  [28,112]. 
A single ABI measurement may not be sufficient for diagnosis even in symptomatic cases 
[108]. In such cases, the patient is asked to perform a standardized exercise, after which a 
ABI is recalculated [108]. Many vascular laboratories use a standardized exercise protocol 
[113], this may involve treadmill walking at a 12-degree incline, at 2 mph, for at least 5 
minutes or graded bike pedalling [108]. Decreases in post exercise ankle pressure of 20 
mmHg or more is indicative of severe PAD [108]. While the ABI is a simple test, it can be 
time consuming and requires training and experience [15]. A recent review highlighted the 
importance of training by comparing sensitivity and specificity of oscillometric ABI and 
manual Doppler ABI performed by inexperienced operators [107]. While oscillometric ABI 
provides sensitivity of 97% and specificity of 89%, manual Doppler ABI has sensitivity of 
95% and specificity of just 56% compared to angiography [107,114]. Xu et al reviewed 
sensitivity and specificity of ABI in detecting/excluding PAD and found the sensitivity values 
between 61%-96% and the specificity range within 56%-90% [60,61,115–121]. An ABI test 
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typically takes about 15 minutes [122], and should be preceded by a 30-minute rest period 
[60]. While ABI is useful as an initial clinical test to assist diagnosis, not all guidelines 
promote the ABI as a screening tool for PAD in primary care [16]. The ABI is unable to 
identify the location of arterial stenosis/occlusion [28], is not recommended as a PAD 
screening tool in primary care by all guidelines  [16] and is not capable of  diagnosing CVI or 
DVT.  
Segmental Blood Pressure Measurement 
Segmental blood pressure measurement, unlike ABI measures, can be used to localize the site 
of stenosis or occlusion in PAD [28,108,123,124]. Four cuffs are placed around the leg, 
ankle, calf, lower thigh and upper thigh [123,124] with either handheld Doppler ultrasound, 
photoplethysmography, strain-gauge plethysmography, or oscillometric blood pressure 
measurement then used to measure the blood flow/pressure at each of the four leg cuff sites 
[108,123].  
A reference arm blood pressure measure is also taken and normally is at least 30mmHg lower 
than thigh pressure [108,123,125]. In healthy individuals the pressure difference (gradient) 
between two adjacent levels in the lower extremities should be 20mmHg or less [86,108]. A 
pressure gradient of 20-30 mmHg is representative of stenosis with greater pressure 
reductions indicating occlusion [123,126,127]. A pressure difference ≥ 20 mmHg between 
the bilateral leg segments also indicates arterial occlusion [124]. 
Limitations of this method include inappropriate cuff sizing resulting in false blood pressure 
readings [123]. An average error of 8.5mmHg in systolic blood pressure is reported due to 
inappropriate cuff sizing [123,128]. Accuracy can be improved by including other measures 
such as arterial pulse wave analysis [108], although no documented accuracy values are 
available. 
Toe Brachial Index (TBI)  
Toe blood pressure measurements to evaluate peripheral arterial disease was introduced in 
1965 [127,129] and is particularly common for the diagnosis and management of underlying 
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vascular pathology associated with diabetic foot lesions [129–131]. Similar to ABI, TBI is 
calculated by dividing the toe systolic pressure by the brachial pressure. TBI is recommended 
as an alternative to ABI to counter unreliable elevated measures in the presence of medial 
artery calcification, which is particularly prevalent in people with diabetes and the aged [132–
134]. 
A study of 174 subjects with diabetes and 53 non-diabetic subject found that diabetic patients 
with an ABI < 1.3 had ABI-TBI differences within the normal ranges for healthy controls, 
whereas those with an ABI ≥ 1.3 had abnormal ABI-TBI differences [132]. The authors 
suggest that there is no advantage to TBI over ABI where ABI < 1.3 but that the TBI is 
superior in the presence of calcification, where ABI ≥ 1.3 [28,132]. While exact threshold 
values for TBI are still debated, a TBI ≥ 0.7 is generally reported to be normal with a TB < 
0.7 associated with claudication and a TBI < 0.2 with pain at rest [28].  
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A review of 22 studies [133] found TBI threshold levels to indicate PAD ranging from 0.54 
to 0.75 [121,132,135–155]. Despite this range in TBI threshold values, TBI has high 
sensitivity (90% to 100%) compared to angiography, with specificity values between 65% to 
100% [133]. Several guidelines have suggested using TBI<0.7 as the threshold, however, 
based on Høyer et al.’s review this cut-off is not necessarily evidence-based. According to 
Høyer et al.’s findings, there is a lack of agreement on TBI diagnostic threshold in the current 
literature and more trials are required to recommend the best diagnostic threshold [133]. Test 
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required to rest for at least 5 minutes before the measurement, the room temperature should 
be above 22 ̊C and toe skin temperature ≥ 25 ̊C [129]. Pre-test limb heating may be required, 
in order to minimize false positive results [133,156,157]. 
The measurement of toe blood pressure is technically more complicated than measuring ankle 
blood pressure [132]. The additional equipment required, such as photo-plethysmography, 
strain gauge plethysmography and Doppler flowmeter, can limit use in some clinical settings 
[132,133].  
Summary and Limitations of Blood Pressure Methods 
Although the ABI is relatively cheap, requiring minimal and inexpensive equipment, and is 
widely clinically applied, it has a low sensitivity when used in patients with diabetes or the 
elderly with calcified arteries, where the ABI values are inflated mimicking false negative 
normal values [28]. This is especially troublesome as these two groups of patients are at 
higher risk of developing PVDs. TBI can be used as an alternative in cases with the presence 
of medial artery calcification, but adds an additional time constraint. To assist in pathology 
site location additional segmental blood pressure measurements can be used. Table 1.5 
provides a summary of the discussed blood pressure methods studies. 
1.1.6 Emerging Techniques 
Pulse Wave Velocity (PWV) 
Pulse wave velocity (PWV) is defined as the velocity at which the arterial pulse wave, 
generated by heart contraction, propagates through the arteries [158]. The application of pulse 
wave velocity as a measure of arterial stiffness/elasticity was first predicted by Thomas 
Young in 1808 [159]. Later, Moens and Korteweg independently presented a mathematical 
model indicating the relationship between pulse wave velocity and arterial stiffness [160]. 
Based on the Moens-Korteweg equation, PWV = E. h 2ρ. r (E: intrinsic stiffness of the 
wall of artery, h: thickness, r: radius, ρ: blood density), higher PWV is representative of 
increased stiffness of arteries [160,161]. Patients with PAD are reported to have a higher 
aortic PWV compared to healthy controls [162]. However, PAD is not the only potential 
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cause of arterial stiffness, as arteries may become stiffened in the presence or absence of 
PAD, e.g. hypertension and diabetes [158].  
Although the use of PWV as a diagnostic measure is quite old, its use for the diagnosis of 
PAD is relatively new. In two studies with sample sizes of 105 and 440 healthy subjects and 
35 and 38 subjects with PAD, PWV was reduced in the presence of PAD when measured 
between the heart-feet [163] and femoral-dorsalis [164]. However, increased heart-feet PWV 
was observed in patients with hypertension, suggesting that PAD and hypertension apply 
opposing effects on PWV [163]. Even beat to beat blood pressure variability have shown to 
be correlated with an increase in PWV in the hypertensive population [165]. Additionally, in 
a study of 101 healthy subjects and 102 patients with diabetes with/without PAD, reduced 
brachial-ankle PWV (baPWV) was found in people with diabetes and PAD (1221 cm/sec) 
compared to non-PAD diabetic subjects (1607cm/sec) [166]. The median difference between 
absolute right-left baPWV was 36 cm/sec in the healthy group, 55 cm/sec in the diabetic/no 
PAD group and 290 cm/sec in the diabetic/PAD group suggesting the right-left difference 
may be used as a novel indicator of PAD [166]. However, cautious interpretation is needed 
when bilateral PAD is present and comparisons to ABI measures which have poor sensitivity 
in the presence of calcification [166]. 
The application of PWV as a measure of arterial stiffness has been motivated by the 
development of new devices to assist measurement. In a recent review PulsePen (DiaTecne, 
Milan, Italy), Complior (Colson, France), SphygmoCor (AtCor Medical, Sydney, Australia), 
Photoplethysmography, ultrasound and Magnetic Resonance Imaging (MRI) have been 
identified for non-invasive PWV measurement [167]. A number of other optical devices are 
identified but are not commercially available [167]. While a promising area of inquiry, PWV 
measurement is currently not used for clinical diagnosis of PVD. Limitations include the 
expense of ultrasound and MRI methods and poor accuracy in more affordable alternatives 
[167]. As discussed earlier, PAD is not the only parameter that alters PWV. The use of PWV 
as an indicator of PAD is complicated by the effects of ageing, arterial stiffness, 
hypertension, beat to beat blood pressure variability, and diabetes. Considering the work to 
date, it is still possible that PWV could be used for PAD diagnosis. However, no studies have 
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compared PWV with validated diagnostic techniques; consequently, no values of sensitivity 
or specificity are reported. 
Vascular Optical Tomographic Imaging (VOTI) 
Vascular Optical Tomographic Imaging (VOTI) is a new non-invasive imaging system, 
which can be used to directly measure distal perfusion in the foot by extracting information 
about haemoglobin concentration [168]. Although VOTI has not been routinely used in 
vascular clinics yet, this system has the potential to be used as a new diagnostic tool for 
peripheral arterial disease [168]. The VOTI system has a sandal shaped measuring probe 
encompassing the foot (Figure 1.3), which uses harmless red, and near infrared light (650 nm 
<wavelength<900 nm) to illuminate the foot at different points. 
The system uses the transmitted lights to construct a cross-section image of haemoglobin 
concentration at the mid metatarsal region. Lower light intensities are indicative of higher 
haemoglobin concentration, which is itself representative of better perfusion [168]. 
The VOTI system was originally introduced in 2007 and in 2015 the system was used to 
assess PAD in the lower extremities of a group of 40 subjects [168]. Subjects were classified 
into healthy (n=20), PAD (n=10) and PAD with diabetes (n=10) groups according to a 
combination of the patients’ ABI readings, segmental ultrasound results, physical symptoms, 
and medical history [168]. Haemoglobin concentration was extracted during staged occlusion 
and compared with ABI readings and arterial pulse wave recordings. Haemoglobin 
concentration for healthy subjects was found to be about twice that of patients during 
60mmHg venous occlusion, with a faster response to pressure application/release in healthy 




Figure 1. 3.  VOTI system and its sandal shaped measuring probe [168]. 
PAD patients with diabetes, similar haemoglobin time traces were observed in both cohorts, 
suggesting VOTI may have greater sensitivity in people with diabetes and PAD [168]. 
1.2 Research Motivation 
The presented literature review discussed the current non-invasive hemodynamic monitoring 
techniques and demonstrated their potential for the non-invasive assessment of peripheral 
vascular function. A summary table including the reviewed methodologies together with their 
performance (where available) in terms of sensitivity, specificity and accuracy is associated 
with this thesis as supplementary material.  
Considering the prevalence and the adverse impacts of PVDs, it is no surprise that many 
diagnostic methods have been developed since the 1670s. The timeline in Figure 1.4 shows 
the advent of milestone technologies for non-invasive diagnosis of PVD. Despite the efforts 
in the development of an ideal non-invasive diagnostic modality for PVDs, underdiagnosis in 
the primary care is still an ongoing challenge, which demands development of new 





Figure 1. 4. Advent of milestone technologies for non-invasive diagnosis of PVDs 
Plethysmographic methods have the best utility to detect both arterial and venous disease 
including occlusions, chronic venous insufficiency and deep vein thrombosis. However, 
plethysmography devices are cumbersome and require a highly trained practitioner limiting 
their use.  Plethysmography assessment also takes a considerable amount of time to complete, 
and typically lacks the potential to localize the site of stenosis/occlusion. 
Doppler methods can provide information about the location of vascular dysfunction. Duplex 
ultrasound is the gold standard method for PVD diagnosis and is the most sensitive non-
invasive method that currently exists. However, similar to plethysmographic techniques, 
expensive equipment and highly trained practitioners are required. Also, Doppler vascular 
assessment is even more time consuming than plethysmography. As such plethysmography 
and Doppler methods have limited use for PVD screening or everyday use in the clinic. 
In contrast, ABI is relatively simple, fast and cheap and is recommended as an initial 
diagnostic tool in primary care, however it has poor sensitivity in patients with calcified 
arteries. Similar to plethysmography, ABI lacks localization capability. Other versions of 
brachial methods, such as the segmental blood pressure measurement, can assist pathology 
localization and toe brachial methods can counter medial artery calcification, increasing 
specificity for people with PAD and diabetes.  However, segmental pressure measurement is 
not reliable and the toe brachial index requires more time than an ABI, and specific 
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Many non-invasive methods have been developed to aid the diagnosis of PVDs. However, 
given the rising number of patients with PVD and the shortcomings of current methods, there 
is still a need for new non-invasive diagnostic tools. The continuous effort for proposing non-
invasive techniques for diagnosis of PVDs over more than three hundred years further 
highlights the need for developing new diagnostic techniques. While Duplex ultrasound and 
plethysmography can be excellent means of PVD diagnosis, training requirements limit their 
more widespread use. Any potential alternative should be intuitive and simple to use, 
minimizing these training requirements. The high cost of Doppler ultrasound and 
plethysmography devices is another hurdle against their availability. While asymptomatic 
patients are also at high risk of morbidity/mortality, the time and cost of such diagnostic 
methods typically limits their use for symptomatic patients. Ideally, a new solution should 
provide an early diagnosis of both arterial and venous diseases accurately, easily, cheaply, 
quickly and without extensive training. 
1.3 HeMo 
Recently, the use of polymer-based sensors has shown potential for diagnosis of PVDs. Such 
sensors basically consist of two main components, a highly elastic polymer carrier (e.g. 
rubber) and an integrated conductive element (e.g. carbon). Typically, deformation of the 
sensor generates proportional changes in the impedance of the sensor.  
Boland et al. introduced two new polymer-based sensors, one created by infusing exfoliated 
graphene into natural rubber [172] and another, G-putty, made by adding graphene to 
commercially available silicon polymer (Silly Putty, Crayola, Easton, PA) [173]. Both of 
these sensors are highly stretchable and capable of capturing arterial pulse waves [172,173]. 
These graphene polymer composites are low cost and can provide high sensitivity and 
extensibility (performance beyond 800% strain) [172]. However, neither the graphene-rubber 
strain sensor nor G-putty is yet commercially available. 
In 2014 Breen et al., researchers at the MARCS Institute, used commercially available 
Conductive Rubber Cord Stretch Sensors (available from Adafruit, NY, USA), also known as 
Electro Resistive Bands (ERB), to visualize peripheral blood flow [33]. The carbon-black 
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impregnated rubber ERB sensors, have fixed resistance at rest, with impedance increasing 
when stretched. The ERB sensors were incorporated in a stretchable piece of fabric to build a 
novel hemodynamic monitoring device, HeMo. The initial design and testing of HeMo 
showed its potential for monitoring blood volume changes in the leg, which could potentially 
be used as measure for diagnosis of peripheral vascular diseases.  
1.4 Research Aims 
The development and validation of any new medical device begins with understanding user 
needs and then designing a device to meet these needs. User needs are reduced to a set of 
design inputs, which for the most part describe technical requirements of the device. The 
design process involves capturing the outputs of design and verifying these meets the device 
requirements and design inputs. A higher-level validation of the device follows, determining 
if the medical device meets user needs entirely. The work presented in this thesis is not 
produced within the framework of a medical device quality management system. However, 
the research in this thesis investigates several hypotheses to provide a proof of concept and to 
discover if HeMo is even reasonable prospect. 
This thesis investigates the following research hypotheses/questions, which are in fact a set of 
requirements for the development of HeMo as a new medical device. 
• HeMo can measure venous refilling time and provide information about venous 
competence in the lower leg (Chapter 2 and 4). 
• HeMo can reliably capture arterial pulse waves and provide information about arterial 
function in the lower leg (Chapter 2 and 5). 
• The electro-resistive bands used in HeMo have sufficient reliability over time and 
linearity making them suitable for wearable measurement functions over time  
(Chapter 3). 
• There is an agreement between HeMo and light reflection rheography in measurement 
of venous filling in healthy volunteers (Chapter 4). 
• Exercise has minimal impact on HeMo venous filling measurements (Chapter 4). 
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• There is an agreement in arterial pulse wave morphology between HeMo and 
photoplethysmography recordings in healthy volunteers (Chapter 5). 
• Exercise has a minimal effect on HeMo arterial pulse wave recordings (Chapter 5). 
Overall, the purpose of this research is to step towards providing an intuitive and user-
friendly version of the HeMo device for clinical use and validate its performance for the 
assessment of peripheral vascular diseases. In a similar fashion to how the 
sphygmomanometer changed the diagnosis and treatment of hypertensive disease by 
providing a simple means of measuring blood pressure, it is hoped that the results of this 
research can lead to a similar result for peripheral vascular diseases. 
1.5 List of Publications 
The work presented in this thesis has resulted in two first-author journal articles and three 
conference papers. A further two research papers comparing HeMo and VasoScreen are in 
preparation. These publications [174–179] are listed below. 
1. Gaetano D. Gargiulo, Elham Shabani Varaki, Tara J. Hamilton, Paolo Bifulco, Mario 
Cesarelli, Maria Romano. A 9-independent-leads ECG system from 10 electrodes: A practice 
preserving WCT-less true unipolar ECG system. IEEE Biomedical Circuits and Systems 
Conference; 2015. p. 1–4. 
2. Elham Shabani Varaki, Paul P. Breen, Gaetano D. Gargiulo. HeMo: Towards an 
inexpensive wearable peripheral blood flow monitoring device. IEEE Biomedical Circuits 
and Systems Conference; 2015. p. 1–4.   
Awarded IEEE CAS Charles Desoer Life Science Systems Student Grant, IEEE Biomedical 
Circuits and Systems Conference 2015, Atlanta, USA. 
3. Elham Shabani Varaki, Gaetano D. Gargiulo, Paul P. Breen. Towards Low-Cost Non-
Invasive Assessment of Peripheral Vascular Function. Presented at Cardiac Society of 




Awarded Best Commercialization Idea Prize from Capital Markets Cooperative Research 
Centre, Western Sydney University HDR Showcase 2016, Sydney, Australia 
Awarded Best Commercialization Idea Prize from Capital Markets Cooperative Research 
Centre, Western Sydney University HDR Showcase 2017, Sydney, Australia 
4. Gaetano D.Gargiulo, Upul Gunawardana, Aiden O’Loughlin, Mohammad Sadozai, Elham 
Shabani Varaki, and Paul P. Breen. A Wearable Contactless Sensor Suitable for Continuous 
Simultaneous Monitoring of Respiration and Cardiac Activity. Journal of Sensors. 2015; 
2015:1–6. 
5. Elham Shabani Varaki, Paul P. Breen, Gaetano D. Gargiulo. Quantification of a Low-
Cost Stretchable Conductive Sensor Using an Expansion/Contraction Simulator Machine: A 
Step towards Validation of a Non-invasive Cardiac and Respiration Monitoring Prototype. 
Machines Journal. 2017; 5: 22. 
6. Elham Shabani Varaki, Gaetano D. Gargiulo, Paul P. Breen, Quantification of a 
Wearable Contactless Sensor Using an Expansion/Contraction Simulator Rig, International 
Conference of the IEEE Engineering in Medicine and Biology Society. 2017. 
7. Elham Shabani Varaki, Gaetano D. Gargiulo, Stefania Penkala, Paul P. Breen. Peripheral 
vascular disease assessment in the lower limb: a review of current and emerging non-invasive 
diagnostic methods. Biomedical Engineering Online Journal. 2018;17:61.  
1.6 Thesis Organization 
Chapter 1 of the presented thesis provides a comprehensive literature review of the existing 
non-invasive diagnostic devices developed since 1677. This chapter is formatted as a review 
article, and has been peer-reviewed and published in Biomedical Engineering OnLine 
journal.  
Chapter 2 discusses the simplified circuit of the HeMo device, and presents pilot data 
demonstrating the potential of HeMo for diagnosis of peripheral arterial disease and chronic 
venous insufficiency. Chapter 2 is a combination of two peer-reviewed conference papers. 
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Chapter 3 presents characterisation of electro-resistive band sensor behaviour during 
contraction and expansion. A reformatted version of this chapter is also peer-reviewed and 
published in the journal Machines.  
Chapter 4 presents data from a healthy population, assessing the performance of HeMo 
compared to light reflection rheography (LRR sensor-VasoScreen 5000) for the assessment 
of venous function.  
Chapter 5 presents human study data where the performance of HeMo is compared to photo 
plethysmography (PPG sensor-VasoScreen 5000) for the assessment of arterial function.  
Chapter 6 concludes the thesis by discussing future directions and the overall contribution of 
the research. 
Appendix A provides matlab scripts of the graphic user interfaces developed for venous and 
arterial assessment associating with their corresponding user guidelines. 
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Chapter 2 Pilot Assessment of HeMo 
This chapter introduces the HeMo device in detail and demonstrates its potential for the 
diagnosis of peripheral arterial disease and chronic venous insufficiency. First, it provides a 
brief background, restating the motivation behind the development of HeMo. It then presents 
the specification of a simplified HeMo embodiment. The remainder of the chapter illustrates 
a series of experiments that demonstrate the potential of HeMo for assessment of both arterial 
and venous function. 
Some of the work presented in this chapter has been published in: 
Shabani Varaki E, Breen PP, Gargiulo GD. HeMo: Towards an inexpensive wearable 
peripheral blood flow monitoring device. 2015 IEEE Biomed Circuits Syst Conf. IEEE; 2015. 
p. 1–4.” 
“Shabani Varaki E, Gargiulo G, Breen P. Towards Low-Cost Non-Invasive Assessment of 
Peripheral Vascular Function. Hear Lung Circ. Australasian Society of Cardiac and 




Peripheral vascular diseases (PVDs) such as peripheral arterial disease (PAD), chronic 
venous insufficiency (CVI), and deep vein thrombosis (DVT) are highly prevalent and often 
go undiagnosed with more than 50% of patients with PAD being asymptomatic [28,180]. 
Although a variety of techniques are available for the diagnosis of PVDs, some of the 
existing methods are highly invasive while others require highly skilled operators and 
expensive equipment. Therefore, there is a need for a new method of PVD diagnosis, ideally 
one that is non-invasive, fast, cheap and easy to use. 
In order to diagnose PVDs, a number of non-invasive tools have been developed (see 
Chapter 1). For example, the Ankle-Brachial Index (ABI) is a simple non-invasive measure 
of peripheral arterial perfusion and is measured by dividing the ankle blood pressure by the 
higher of two brachial pressure [28]. However, ABI measurement may take up to 15 minutes 
to complete [183] and an additionally 30 minutes rest before the test may be required [60]. 
Moreover, it has been argued that the ABI may appear normal or even supernormal for 
patients with diabetes, renal disease or the elderly whose arteries are thickened [28]. 
Plethysmography is also a non-invasive technique for the evaluation of peripheral vascular 
competence. Several different types of plethysmography devices exist; impedance, photo, 
strain gauge and air plethysmography have all been utilized to measure blood flow changes 
[180]. Plethysmography measures venous and arterial function [39], and as Harada has 
reported [184], the venous filling index measured by plethysmography has a 100% positive 
predictive value of diagnosing venous insufficiency. Furthermore, Anderson has argued [40] 
that impedance plethysmography has a sensitivity and specificity of more than 90% for 
arterial disease diagnosis. Nevertheless, current embodiments of plethysmography are 
cumbersome, time consuming and require highly trained practitioners [185], factors that have 
limited their adoption in clinical practice.  
Another non-invasive method for PVD diagnosis is duplex ultrasonography (DU) which 
allows the anatomy and functionality of vascular system to be defined [186]. DU is a highly 
sensitive diagnostic tool [87], and it is capable of providing information about the site and 
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extent of deep vein thrombosis or venous reflux [98]. However, a DU examination takes 
approximately 45 minutes and the quality of the test results are dependent on operator 
experience [181], [187]. Some patients cannot undergo DU due to leg swelling, ulceration, 
pain or heavily calcified arteries [3]. Moreover, DU is an expensive test and in practice is 
reserved for patients with clear symptoms [180].  
A new non-invasive blood flow monitoring technique is required to overcome the limitations 
of the existing methods. Breen et al. previously reported the development of an inexpensive, 
wearable, user-friendly device called HeMo for evaluating the peripheral blood flow 
monitoring non-invasively [33].  
In simple terms, the shape of the arterial pulse is a guide to peripheral arterial disease (PAD) 
diagnosis [185]. A normal arterial pulse wave (Figure 2.1) has a steep upslope, a relatively 
narrow peak, and a dicrotic notch on the downslope [185]. Any arterial incompetence such as 
stenosis or occlusion affects arterial pulsation, so PAD can be detected by comparing the 
arterial pulse waveform of a patient with a grading system [192]. Progress of PAD is 
evidenced by the disappearance of the dicrotic notch, dampening the wave amplitude and 
flattening the systolic peak. Threshold values for maximum systolic slope and arterial pulse 
amplitude exist which may also be used in combination with the HeMo device and which 
have a reported sensitivity and specificity of more than 90% [40]. 
To assess venous competence in the lower limb venous Filling Index (VFI) is usually 
measured and compared to threshold values. The VFI is a parameter, which is defined as 90% 
of the venous volume at rest divided by the time required for venous refilling to 90% of 
resting volume after returning to the standing position [8]. A simple manoeuvre is required to 
measure the VFI. First, the resting venous volume is measured in the standing position. 
Second, the patient’s leg is elevated while supine to reach minimum venous volume. Then, 
the patient is asked to resume to the upright position. A VFI of less than 2 ml/s is inferred as 
normal, while presence of venous reflux is evidenced by higher VFI values of 2-7 ml/s 
[39,184]. A VFI > 7ml/s has been reported to have a 100% positive predictive value for 
critical venous reflux diagnosis [184]. Similar to VFI, Venous Filling Time (VFT) is also a 
parameter that is used to assess venous competence in the lower limb.  A VFT greater than 20 
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seconds is reported to represent normal venous function, VFT values less than 20 seconds 
infer chronic venous insufficiency [49,193]. 
 
Figure 2. 1. Typical arterial pulse volume waveforms from normal healthy, moderate and severe peripheral 
arterial disease, adapted from [20]. 
In the next section, the HeMo device and its simplified circuit are fully described. Then the 
following sections investigate if HeMo can reliably capture arterial pulse wave and if HeMo 
can measure venous filling index/time. The work presented in this chapter is a proof of 
concept as it is the first use of the HeMo device in comparison with validated sensors, which 
can provide similar information. 
2.2 HeMo System Design 
HeMo is a wearable contactless device (instrumented cuff) worn around the limb (Figure 2.2) 
and capable of measuring blood volume changes in the limb. The principle of operation is 
that changes in the blood volume of the limb induce similar changes to the circumference of 
the cuff. This is captured through measurement of changes in the voltage across the polarised 
electro-resistive bands (ERBs). Using a calibration equation derived against three known 
volumes by interpolation, the output signal is translated into blood volume in ml. HeMo is 
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designed to be unobtrusive and its compression upon the limb is negligible. As a result it may 
be worn for days without affecting daily routines or activities. 
The previous version of HeMo combined volumetric measurements derived from electro-
resistive bands worn around the limb with electrical impedance tomography provided by a 
ring of electrodes worn around the limb in the same region. The previous design incorporated 
electro-resistive bands and electrodes locating on the lower leg, and accelerometers at the 
shank and thigh to enable movement detection [33]. Prior development was limited as it only 
enabled detection of changes in peripheral blood volume with the changes in posture. 
In the development of this technology it was discovered that, with an appropriate amplifier 
arrangement, very small fluctuations in limb volume could be detected using the electro-
resistive bands alone. Here, we introduce this new simplified version of the HeMo device in 




Figure 2. 2. HeMo prototype; (a) A demonstration of HeMo worn on the calf [33]; (b) HeMo cuff (adopted 
from [33]); (c) Diagram of HeMo worn on the calf (adopted from [33]). 
Similar to the previous version, this device incorporates a pair of electro-resistive stretchable 
bands in a wearable cuff (Figure 2.2). In conjunction with amplification and filtering this 
wearable, electrode-less system may be used to non-invasively monitor blood volume shifts 
due to postural changes and arterial inflow into the limb.  
The simplified version of HeMo integrates two electro resistive bands made of carbon-black 
impregnated rubber with a resistance of ~150 ohms/cm at rest. The bands are sewn into the 
top and bottom of a stretchable fabric cuff (Figure 2.2). The electrical block diagram of the 
circuit is shown in Figure 2.3. 
 
Figure 2.3. ERB front-end block diagram. 
The new electro-resistive band (ERB) front-end circuitry is low power, with a measured 
current consumption of 1100 µA when powered at 4.5 V, compared to ~2.5mA in the 
previous version. It employs only three commercial microchips and can be assembled onto 
a 4 cm! double-sided PCB (see Figure 2.4).  
Similarly to the previous design [1], ERBs are polarized using a small DC current. The 
required DC current is achieved using the REF200 by TI [188]. Having only two ERBs, 
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contrary to the previous designs which required adjustable current levels [189], one single 
REF200 contains two independent 100 µA current generators which can be used to 
independently polarize both ERBs. Although HeMo is contactless (the ERBs are assembled 
on the outside of the cuff), the design is micro-shock safe [190] with the largest DC current 
that can flow through the body of the patient or operator being 200 µA. 
Summation of the ERB voltages is achieved directly by the analogue circuits using a true 
differential amplifier (INA116 by TI [191]). In order to achieve summation and not 
subtraction of voltages, the current was forced through the ERB connected to the inverting 
input such that it generates a negative voltage with respect to the signal ground. Negative 
voltage compliance for the current generators is achieved using an isolated DC-DC converter 
module (DHC10512D by TI) which generates a dual unregulated power supply of up to 
±14 V from a single power supply of 4.5 V (5 V power supply nominal specification). For 
this application HeMo was powered using the 5 V output of the National Instruments NI6009 
that was also employed to acquire the data. Although the signal output of the INA116 does 
not require amplification, in order to accommodate the low dynamic range of the ADC used 
during our tests (14 bit, ±5 V), a gain of 6 V/V is achieved using a single 10-kΩ resistor 




Figure 2. 4. PCB views (not to scale), top layer (red) and bottom layer (blue). Power is supplied via connector 
JP, signal is presented at connector JO. 
The net blood volume inflow is extracted from the raw volume signal using an amplitude 
compensated software (MATLAB) high-pass IRR filter (50th order) with a cut off frequency 
at 0.3 Hz. The filter is designed to remove the large DC component due to the large volume 
of the limb under examination (hundreds of ml) and also removes some unwanted trends in 
volume due to slow filling of other fluids or relaxation of the muscle due to particular 
postures (e.g. leg elevated above the heart).  
2.3 Description of use 
To investigate the potential of HeMo for arterial and venous assessment, a healthy volunteer 
participated in a series of experiments and data were recorded while the volunteer was 
barefoot and wearing shorts. Two experiments were performed to investigate the potential of 
HeMo in arterial assessment and two other experiments were performed for investigation of 
venous assessment with HeMo. To record data from HeMo, the fabric cuff is simply worn 
around the leg and changes in blood volume in the leg can be recorded. Either postural 
changes, movement and arterial inflow can induce variations in the inscribed volume of the 
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HeMo cuff resulting in changes to the length the ERB sensors and so the voltage across the 
sensor. 
Arterial assessment was performed while the subject was sitting relaxed on a chair, HeMo 
was worn on the leg and a piezo-based pulse sensor was placed on the toe and data were 
recorded from both simultaneously. In a similar manner and for the same subject, HeMo 
recording was also compared with a recording from a clinically validated 
photoplethysmography sensor. 
The volume variations due to postural changes were tracked to provide the venous 
assessment. Data from the volunteer was recorded in multiple positions (standing, lying down 
with the leg elevated) to measure VFI. Another experiment was done in which the same 
volunteer was sitting on a chair with HeMo on the leg and a light reflection rheography 
sensor placed on the inner side of the leg below the HeMo cuff. Data from both HeMo and a 
clinically validated sensor, light reflection rheography, were recorded simultaneously before, 
during and after ten consecutive dorsiflexion manoeuvres to compare VFT values measured 
with HeMo and light reflection rheography. 
The experiments for capturing the arterial pulse wave and measurement of VFI/VFT are fully 
described in the following sections. 
2.4 Pilot Experiment 1: Measuring the Arterial Pulse Wave 
Arterial data was captured using a toe-worn MP100 pulse transducer from AD Instruments 
while HeMo simultaneously collected data from the calf of the same limb of a healthy 
volunteer with no history of peripheral vascular diseases. 
A comparison of lower limb arterial inflow as simultaneously measured by a toe-worn pulse 
transducer and the calf-worn HeMo device is shown in Figure 2.5. A small phase difference 
is evident between the two recordings; this delay is due to the fact that the HeMo device 
tracks volume changes while the piezo based pulse transducer is acceleration sensitive. 




A dicrotic notch is clearly visible in the HeMo recording (Figure 2.5) indicating a normal 
healthy arterial system. Additionally, it should be noted that the recorded data using HeMo is 
calibrated in ml. This capability would potentially allow HeMo to track arterial disease 
progression or treatment at different time points. 
 
Figure 2. 2. Arterial pulse wave comparison; Top: Arterial pulse recorded by HeMo (raw data): Bottom: MP100 
pulse piezoelectric transducer. 
2.5 Pilot Experiment 2: Comparison to Photoplethysmography 
In a second evaluation to investigate the potential of HeMo for arterial assessment, a healthy 
volunteer with no history of peripheral vascular disease sat upright in a chair while HeMo 
was worn on the thickest part of the calf. A photoplethysmography sensor (PPG, VasoScreen 
5000, Medis) was placed on the subject’s big toe of the same leg. With this setting, we were 
able to record the arterial pulse wave from HeMo and PPG simultaneously. 
A comparison of arterial pulse wave in the lower limb, simultaneously measured by the PPG 
sensor and the HeMo device is shown in Figure 2.6. A small phase difference is evident 
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between the two recordings, as each sensor captured the arterial pulse at different sections of 
the lower limb.  
 
Figure 2. 3. Arterial Pulse wave recording; Top: recorded with PPG; Bottom: recorded with HeMo. 
Again, the dicrotic notch is clearly visible with both systems, indicating a healthy arterial 
system at a cursory level. Moreover, it should be noted that the while the recording from 
photoplethysmography has an arbitrary unit, the HeMo recording can be calibrated in ml. 
In a further extension of this work, ten tiptoe manoeuvres were performed while HeMo 
recorded changes in arterial inflow. Figure 2.7 presents the calibrated data before, during and 
after the ten tiptoe manoeuvres. The arterial pulse shape changes noticeably following the 
brief exercise and the pulse volume increases substantially. Data in insets have been extracted 




Figure 2. 4. Blood flow variations before (lower left inset), during and after ten tiptoes (lower right inset). 
2.6 Pilot Experiment 3: Measuring Venous Filling Index 
VFI can be easily measured using the HeMo device. The calf volume is measured at rest, 
with the leg elevated and again in the standing position, using the output voltage of HeMo 
circuitry and the calibration equation derived from the corresponding output voltages of 
HeMo when it was placed around three known volumes. After the leg elevation manoeuvre, 
the time required to reach 90% of the initial venous volume is calculated to find the VFI.  
The venous filling index was calculated as described for a healthy volunteer with no history 
of peripheral vascular disease and it is shown in Figure 2.7. Following venous emptying via 
leg elevation, the time taken to reach 90% of standing limb volume was calculated. From this 
data the VFI was easily calculated. In this case it was found to be 0.6 ml/s, which would be 




Figure 2. 5. Venous Filling Index (VFI) measurement using HeMo. 
2.7 Pilot Experiment 4: Comparison to Light Reflection 
Rheography 
The experiments presented in sections 2.5 and 2.6 demonstrated that HeMo is capable of 
measuring dynamic blood volume shifts due to both postural changes, and arterial inflow into 
the limb. This experiment compares the performance of HeMo versus a clinically validated 
device for the assessment of venous refilling using light reflection rheography (VasoScreen 
5000, Medis Medizinische Messtechnik GmbH, Ilmenau, Germany).  
To examine the capability of HeMo for assessing venous functionality, venous filling time 
(VFT) measured simultaneously by HeMo and light reflection rheography (LRR) were 
compared. VFT is defined as the time required for venous filling after exercise [59].  
To measure VFT with HeMo and LRR, a healthy volunteer with no history of peripheral 
vascular disease was asked to sit on a chair and wear HeMo on the thickest part of the calf. 
The LRR sensor was placed on the inner side of the same leg and about 10 cm above 
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malleolus as described in the LRR device manual, a small distance below HeMo. The subject 
was asked to follow ten metronome sounds, which were generated by the reference device, 
and perform ten consecutive dorsiflexion manoeuvres.  
Venous filling simultaneously recorded by HeMo and LRR is shown Figure 2.9. Following 
venous emptying via repeated dorsiflexion, the venous filling time was calculated from the 
recorded data. Both devices were closely matched with a calculated venous filling time of 
approximately 45 seconds indicating normal venous function. 
 
Figure 2. 6. Venous filling time measurement; (a) is recorded with LRR sensor; (b) is recorded with HeMo. 
2.8 Conclusion 
While a previously developed HeMo embodiment for non-invasive monitoring of peripheral 
blood flow used electrical impedance measurements, in this chapter, a simplified version is 
presented which is more wearable, easier to use and cheaper to build [33]. As a result, we 
have a simplified system, which is still capable of measuring dynamic changes in limb blood 
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volume. The results presented in this chapter also show the sensitivity of HeMo to blood 
volume fluctuations due to arterial inflow, postural changes and following dorsiflexion.  
These pilot comparisons between HeMo and a piezo pulse transducer, photoplethysmography 
and light reflection rheography in healthy volunteers allowed us to rapidly assess if this 
embodiment of HeMo is capable in providing the required information for the assessment of 
arterial and venous perfusion in the lower limb. These preliminary comparisons demonstrated 
that HeMo measurements and those from validated clinical sensors match closely, proving 
the concept to be valid. This justified further development and investigations in a larger 
population.  
However, it should be noted that at this point, the electrical behaviour of the electro-resistive 
band sensors during expansion and contraction is not fully known. In the next chapter, this 
issue is addressed, presenting an expansion/contraction simulator machine, which enables 
investigating of the electrical behaviour of the electro-resistive sensors for a range of 
expansion/contraction frequencies. Using the data collected from this rig we provide 




Chapter 3 Characterisation of Electro-Resistive 
Band Sensors 
This chapter provides the characterisation of electro-resistive band behaviour during 
expansion and contraction. First, a brief background, introduces different stretchable electro-
resistive band sensors. It then introduces a custom test rig, developed to provide continuous 
expansion and contraction of the electro-resistive band sensor. Data analysis methods are 
presented and followed by results quantifying the behaviour of the electro-resistive band 
sensors. Finally, a discussion is provided to highlight the benefits and limitations of the work 
described in this chapter. 
Some of the work presented in this chapter has been published in: 
Elham Shabani Varaki, Paul P. Breen, Gaetano D. Gargiulo. Quantification of a Low-Cost 
Stretchable Conductive Sensor Using an Expansion/Contraction Simulator Machine: A Step 
towards Validation of a Non-invasive Cardiac and Respiration Monitoring Prototype. 




Wearable sensors have recently attracted a lot of attention as their deployment in biomedical 
applications has generated new possibilities for health monitoring, treatment assessment, 
early detection of health disorders, prevention of their complications and ultimately reducing 
health care costs [194,195]. 
While traditional health care systems are often limited to use within the clinical environment, 
wearable sensors can be embedded in ordinary clothing enabling convenient, low-cost 
implementations in the home and community settings [196]. Stretchable electro-resistive 
sensors have shown potential for use as wearable strain sensors fulfilling the requirements of 
future technology, particularly in the monitoring of human activity and personal healthcare 
[197,198]. Consequently, a great deal of effort has been recently dedicated to the 
development and characterisation of such sensors. Generally, stretchable electro-resistive 
sensors incorporate two main components, an integrated conductive component (e.g. carbon-
black, graphene, nanowires) and a flexible support material (e.g. silicon-based elastomers, 
rubber-based elastomers) [197]. These sensors operate through their mechanical deformation, 
inducing changes in the resistance of the sensor, which ultimately can be monitored as an 
electrical signal [197]. However, these sensors may respond differently depending on their 
material and fabrication. For example, stretchable electro-resistive sensors have a diverse 
range of gauge factors varying by orders of magnitude i.e. 1 [199–202], 10 [172,201,203–
206], 100 [207–209], 1000 [210] and up to 1000000 [211]. Other characteristics such as the 
linearity, hysteresis, and frequency response of the stretchable electro-resistive sensors may 
also vary from one to another. A careful understanding of these characteristics is crucial for 
appropriate use of such sensors. For instance, nonlinearity of the sensor may result in 
requirement of a more complicated calibration process [197]. Two recent reviews have 
included highly informative details in regards to the performance and applications of different 
stretchable electro-resistive strain sensors [197,198]. According to the existing literature, 
several of the recently introduced stretchable sensors can be used for different health 
monitoring application. For instance, Yamada et al. reported stretchable electro-resistive 
carbon nanotube sensors which could be used either on skin or clothing such as stockings, 
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bandages, gloves to detect various types of motions including limb movement, breathing, and 
speech [199]. Amjadi et al. also reported a highly stretchable electro-resistive sensor made up 
of silver nanowire and a silicon-based organic polymer (Polydimethylsiloxane) and 
demonstrated that the sensor could be used in finger motion detection [201]. Blond et al 
introduced graphene rubber electro-resistive sensors and demonstrated the potential of this 
sensor in the detection of finger/forearm movement, speech and monitoring of heart rate, 
breathing and arterial pulse [173]. Stretchable electro-resistive sensors can be used on skin 
and or clothing providing ubiquitous use and in a wide range of applications. Therefore, 
many more stretchable electro-resistive have been reported [197,198]. However, these 
sensors have only recently been developed, and many are not yet commercially available. 
Commercially available Conductive Rubber Cord Stretch Sensors, also known as Electro-
Resistive Band (ERB) sensors, are normally used for robotic applications and more recently, 
they have been used as wearable sensors to capture a range of bio-signals 
[174,175,178,180,189]. The ERB sensors (available from Adafruit, NY, USA) are made of 
highly elastic carbon-black impregnated rubber and are sold with a length of 1 m and a 
thickness of 2 mm. The ERBs have a defined resistance at rest (~ 15 ohms/cm) and their 
resistance increases as they are stretched. These sensors are cheap, waterproof and are easily 
sewn into fabric, making them ideal for use as wearable sensors, e.g. embedded in a T-shirt or 
knee support [175,178]. This chapter focuses on the quantification of the ERB sensors. 
The ERB sensors were originally created as electromagnetic field (EMF) gaskets and have 
been used as displacement sensors in robotic applications [212]. More recently, these sensors 
have been exploited in several prototype devices with the intention of measuring cardiac 
stroke volume, respiration tidal volume [178,189], and changes in peripheral blood flow 
[174,175,180]. This previous work provided some promising results suggesting that these 
low-cost ERBs were capable of providing valuable clinical information and could lead to a 
viable solution for continuous and non-invasive measurement of respiration, cardiac function, 
and peripheral vascular competence. However, characterisation of ERB sensors is necessary 
to provide a precise pre-calibration of the sensor and/or appropriate post-hoc analysis of the 
data generated. Investigation of the sensor behaviour during expansion and contraction is a 
prerequisite to compensate for possible nonlinearities, which may be detrimental to accuracy 
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and performance. More generally, there is a need for careful quantification of these ERB 
sensors to fully understand their characteristics and define the possible biases and error that 
may be associated with their use. This characterisation will be of interest to other users and 
developers incorporating this type of sensor into their devices. 
In the work presented here, an expansion/contraction rig that repeatedly stretches the ERB 
sensors is described. These bands were tested continuously over the course of four and half 
days and compared the measurements to a string potentiometer. Our aim was to capture 
sufficient data from the ERBs over time, compare these to a gold standard measurement and 
determine if it may be possible to compensate for the predicted non-linearity of the ERBs 
system. 
3.2 Methods 
3.2.1 Expansion/Contraction Simulator Machine 
In order to investigate the existence of possible nonlinear characteristics of the ERB sensor, a 
commercially available linear displacement sensor, a string potentiometer (SP), was used as a 
comparison reference. To have a more informative comparison between the ERB and the SP, 
simultaneous expansion and contraction of both sensors was required over an extended period 
of time. Therefore, a rig was developed to enable simultaneous expansion/contraction of both 
sensors. 
This rig was formed on a platform mounted with a DC gear motor (JGY-370-12 v-12 RPM, 
ASLONG, Shenzhen, China), rotary encoder (E6B2-CWZ6C, OMRON, Osaka, Japan) and 
string potentiometer (SP1-4, Celesco) with a full stroke range of 120 mm (Figure 3.1). To 
capture motor position, the rotary encoder and motor were linked together to using a 1:1 
timing belt. A metal arm was attached to the shaft of the DC motor. Two pulleys were used to 
connect the metal arm to the SP and the ERB independently, enabling a smooth periodic 
expansion/contraction (Figure 3.1). Using this system, the ERB and the SP sensors were 
expanded when the metal arm reached position (a) and the sensors were fully contracted 
when the metal arm reached position (b). Therefore, the rotary motion of the metal arm 
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resulted in sinusoidal stretching pattern for both sensors. Of note, the use of two pulleys 
prevented both sensors affecting each other and enabled simultaneous but independent 
expansion/contraction of the two sensors. 
The DC motor was directly connected to a DC power supply with a voltage of 10 V and the 
rotary encoder was powered using the 5 V output of the USB-X-Series NI USB-6343 
(National Instruments, Austin, Texas, USA), which also acquired the data. The ERB and the 
SP were polarized by a small DC current generated using a REF200 by TI [188]. The 
resultant voltages across the ERB and SP were amplified using two pairs of instrumentation 
and differential amplifiers (INA118 and OPA129) prior to acquisition. 
 
Figure 3.1. Top Panel: Picture of the expansion/contraction simulator rig. System elements: (1) rotary encoder; 
(2) motor; (3) direction of rotation of motor arm; (4) pulley system; (5) string potentiometer; (6) electro-resistive 
band. Bottom Panel: Diagram of the expansion/contraction simulator rig. Maximum stretch of the ERB and SP 
sensors occurs when the DC motor arm reaches position (a), minimum stretch occurs at position (b). 
3.2.2 Data Acquisition 
Four ERBs, all with a length of 292 ± 0.5 mm were used for a comparison against the SP. For 
each of the four ERBs, the sensor was placed in the rig and pre-stretched 10 ± 0.5 mm to 
avoid any slack when fully relaxed. The ERB and SP were stretched 28 ± 0.5 mm (13% of its 
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resting length) when fully expanded by the motor. Of note, the amount of stretch experienced 
by the ERBs is much more than the required stretch of these sensors when it is used in HeMo. 
Therefore, the results presented in this work could be used for the use of ERBs in other 
applications in which greater stretch is required. For example, this stretch is similar to the 
maximum stretch experienced when the ERB sensor is used for monitoring 
respiration [21,22]. 
The rig operated continuously with an average speed of 8.77 rpm for each band over four and 
half days. An epoch of data was recorded every hour, resulting in one hundred and eight 
epochs of data collected for each band. All data were acquired with a sampling rate of 20 kHz 
and acquisition duration of 15 seconds, which guaranteed the capture of at least one full 
rotation of the motor. A much lower sampling rate would have been sufficient to acquire data 
from the ERBs and the SP but we required a high sampling rate as we intended to use the 
rotary encoder data to provide a precise interpolation of the sinusoidal expansion/contraction 
cycle. This interpolation was required to provide a ground truth for confirming the linearity 
of the reference sensor (SP) used in our quantification. 
3.2.3 Data Analysis 
To eliminate high frequency noise, we used a steep low-pass filter derived from modification 
of a filter which we had earlier implemented for post-processing of physiological signals 
[175]. Therefore, all acquired data underwent a 50th order software non-causal (zero phase 
lag) IIR low-pass filter (implemented using Matlab) with a cut-off frequency of 10 Hz. 
Assuming the bands were linear and the rig was perfect, we would have expected a perfect 
sine wave as the output voltage of the ERB during a complete expansion/contraction (one full 
cycle of the motor). This is because, when a mono frequency sinusoidal wave is applied to a 
linear system, a sinusoidal wave with the same frequency component appears as the output 
[213]. In contrast, inputting a mono frequency sinusoidal wave to a nonlinear system results 
in generation of a multi-frequency wave, which contains the fundamental frequency 
component of the input signal and an associated range of harmonics. The existence of 
harmonics at the output of a system with a mono frequency input may then be seen as 
representative of the system’s nonlinearity. Total Harmonic Distortion (THD) is widely used 
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for quantification of the level of nonlinearity due to its sensitivity to the level of harmonics 
and nonlinear effects in electromechanical systems [213]. Therefore, the THD of each ERB 
recording was calculated to determine the similarity of the output voltage to a perfect sine 
wave and so to quantify the level of nonlinearity. However, as no test rig could be perfect and 
instead could be expected to cause some systemic errors, the THD of the SP recording was 
also calculated to provide a comparative reference. The THD is calculated by dividing the 
root sum squared of the harmonics of a waveform by its fundamental frequency. 
To extract the fundamental frequency, we found the frequency at which the Fast Fourier 
Transform (FFT) of the SP data plateaued. The fundamental frequency represents the 
frequency of the oscillation. The extracted fundamental frequency using FFT was also 
consistent with the oscillation frequency of the motor. For example, for a recording at which 
the motor was rotating with a speed of 8.803 rpm, the oscillation frequency of the motor 
(8.803/60=0.1467 Hz) exactly matched with the fundamental frequency extracted from the 
FFT signal of the SP data (0.1467 Hz). The fundamental frequency of the band data also 
matched with the fundamental of the SP data, as they were oscillating at the same speed. 
Harmonic frequencies are defined as integer multiples of the fundamental frequency. 
Therefore, to find the harmonics, the first five multiples of the fundamental frequency were 
extracted. Only the first five harmonics were included in the THD calculation, as these were 
the dominant harmonics and the rest were negligible. The sum of the power of these five 
harmonics was used in calculating THD. Therefore, THD was calculated by dividing the 
power of the first five harmonics by the power of the fundamental frequency. 
Additionally, the Signal-to-Noise Ratio (SNR) and the peak-to-peak voltage of the SP and 
ERB data were also calculated and compared. To calculate the SNR, the maximum frequency 
component of each recording was considered as the signal and remaining frequency 
components were considered as noise. In other words, the power of the fundamental 
frequency was considered as the power of the signal and the sum of the power of the rest of 
frequency components was considered as the power of the noise. All data were normalized 




A representative single low-pass filtered recording acquired from one ERB and the SP during 
a full cycle is shown in Figure 3.2. It is immediately clear that the ERB deviates substantially 
from the SP signal, with a nonlinearity clearly visible in the voltage recording of the ERB 
during contraction (Figure 3.2). Figure 3.3 demonstrates a comparison of normalized ERB 
and SP data. A clear difference exists in the shape of both recordings.  
 






Figure 3.3. Normalized ERB voltage versus Normalized SP voltage. 
 
3.3.1 Total Harmonic Distortion (THD) Comparison  
The ERB voltage signal (Figure 3.2) clearly demonstrates the ERB sensor nonlinearity. The 
THD of the band data and THD of the linear sensor (SP) during repeated simultaneous 
expansion/contraction are shown in Figure 3.4. As the bands and the SP are pulled 
simultaneously, artefacts during the rotation of the motor affect both sensors. While a THD of 
both sensors follow a similar trend, higher THD values are observed for the ERBs compared 
with those of the SP. The difference in THD values may be expected due to the additional 




Figure 3.4. Total Harmonic Distortion of the ERBs and the SP. (1) to (4) refer to the different ERBs 
Table 3.1 summarizes the THD comparison between the ERBs and the SP. The nonzero 
values of the SP signals indicate that the rig does not produce a perfect sinusoidal cycle. This 
emphasizes that the nonlinearity of ERBs can result in more than a 50% increase in the THD 
calculated over four and half days recording.  






1 10.11±1.09 4.87±2.57 
2 12.36±0.87 6.9±1.53 
3 9.07±1.56 4.51±2.47 
4 10.45±0.82 7.13±2.17 
 
3.3.2 Signal to Noise Ratio Comparison 
The signal to noise ratio of all ERBs and the SP are calculated and compared (Figure 3.5). 
Similar to the visual correlation seen in the trend of the THD of the two sensors, SNR trends 
of the bands and the SP are quite similar. As expected, the SNR values of the SP are higher 
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than those of the ERBs, confirming that the ERBs are further affected by additional 
noise/artefact due to the intrinsic nonlinear behaviour of the bands.  
A summary of SNR values of the two sensors is provided in Table 3.2 showing that the mean 
SNR of the ERBs are from 0.25 dB (Experiment 3) to 0.63 dB (Experiment 1) lower than the 
SNR values of the SP (in the same experiment). The difference in the SNR values of the two 
sensors further demonstrates the need for compensation of ERB’s nonlinear behaviour, as this 
would lead to a considerable increase in SNR and ultimately, enabling a more accurate 
measurement with the ERBs. 
 
Figure 3.5. Signal to noise ratio of the ERBs and the SP. (1) to (4) refer to different ERBs. 
 








1 -0.85±0.18 -0.09±0.06 
2 -0.65±0.18 -0.16±0.05 
3 -0.4±0.24 -0.11±0.09 




3.3.3  Peak to Peak Comparison 
The peak-to-peak voltage of all ERBs and the SP for all recordings are shown in Figure 3.6. 
While the SP data remained roughly constant during the whole recording for all experiments, 
a small drift was found in the peak-to-peak voltage of each ERB. The initial drift in the ERB 
peak-to-peak voltage is small and it disappears after about 40 hours. 
 
Figure 3.6. Peak-to-Peak voltage comparison of the ERBs and the SP. (1) to (4) refer to the different ERBs. 
ERB signal drift during the first 40 hours was suspected to be due to initial use of a new 
sensor. To explore this further, data were collected from a brand new ERB 
expanding/contracting for 4.5 days. One epoch of data was saved every hour and again 
observed drift in the peak-to-peak voltage during the first 40 hours, which then stabilises. 
Following this experiment, the ERB was left relaxed for 24 hours before repeating the 
experiment. In the second experiment, the peak-to-peak voltage appeared to be stable and 
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without drift, confirming that the initial drift was due to the initial use of the ERB sensor 
(Figure 3.7).  
 
Figure 3.7. Peak to peak voltage of the band and the SP. The blue lines refer to the first experiment, and the red 
lines refer to the second experiment. The dashed line represents the peak-to-peak voltage of the SP data and the 
solid lines represent the peak-to-peak voltage of the ERB data. 
3.3.4 Correlation Coefficient 
The band data and the SP data were correlated to quantify the overall similarity of the ERB 
behaviour to a linear sensor (SP) behaviour. The mean correlation value calculated for the 
four bands ranged from 0.95 (band 1) to 0.98 (band 3), with an average of 0.97, showing 
strong similarity between the two sensors. Moreover, the variation of the correlation between 
the ERB and the SP data was investigated over time (Figure 3.7). For each band, the 
correlation coefficient was calculated between the recorded band data and the SP data. Since 
one hundred and eight epochs of data were recorded for each band, one hundred and eight 
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correlation coefficient values were calculated for each band during its continuous 
simultaneous expansion/contraction over the course of four and half days. As seen in Figure 
3.8, a drift tendency was also found for correlation of the ERB and the SP data over time. The 
observed drift may refer to the deterioration of the ERB sensors over time.  
 
Figure 3.8. Correlation coefficient of the ERB and the SP sensor for 108 recordings. Different colours refer to 
different bands used in the experiment. 
3.3.5 Frequency Response 
To investigate the behaviour of the ERB sensors for different oscillation frequencies, the 
speed of expansions/contractions was changed. This change was applied either by changing 
the voltage of the power supply which fed the DC motor or by replacing the motor with a 
faster/slower one. Fifty cycles of expansions/contractions were recorded continuously for 
each oscillation frequency. The average temporal response was calculated for each of the 
operated oscillation frequencies (Figure 3.9-a1, b1, c1, d1, e1, f1). Then, each average 
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temporal response was used to measure hysteresis behaviour of the ERB for the operated 
frequency (Figure 3.9-a2, b2, c2, d2, e2, f2). Generally, electro-resistive type strain sensors 
have been reported to show hysteresis especially during under large strains [4]. The sensing 
performance of strain sensors under dynamic loads can become non-reversible when they 
show large hysteresis behaviour. [4]. Therefore, hysteresis can become an important factor 
for the use of such sensors in most of the wearable applications where the sensor experiences 
dynamic loads [4]. Figure 3.9-a2, b2, c2, d2, e2, f2 demonstrates that the hysteresis behaviour 









Figure 3.9. (a1, b1, c1, d1, e1, f1) show the average temporal response calculated for oscillation frequencies of 
0.05 Hz, 0.15 Hz, 0.26 Hz, 0.59 Hz, 0.85 Hz, 2.23 Hz. (a2, b2, c2, d2, e2, f2) show the hysteresis behaviour of 
the ERB sensor for oscillation frequencies of 0.05 Hz, 0.15 Hz, 0.26 Hz, 0.59 Hz, 0.85 Hz, 2.23 Hz. Hysteresis 
is calculated at the midpoint of minimum and maximum strain. Gauge factors are also calculated for each 
oscillation frequency. 
The average hysteresis plots show that the electrical behaviour of the band during expansion 
and contraction would tend to be more similar when there is a small amount of stretch, and 
their electrical behaviour of the two modes show more difference as the strain is increased. 
Moreover, it can be seen that the electrical behaviour of the ERB sensor shows more semi- 
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sinusoidal response when the ERB sensor is stretched/ contracted with smaller oscillation 
frequencies.  
The sensitivity of strain, known as gauge factor, was also measured for the ERB sensor 
operated at different oscillation frequencies. This was calculated by using the average 
temporal responses and simply dividing the relative change in resistance of the ERB sensor 
by the relative change in the length of the sensor. Figure 3.9-a2, b2, c2, d2, e2, f2 illustrates 
that the ERB’s gauge factor decreases as the oscillation frequency increases. However, the 
reduction in sensitivity slightly affects the peak to peak voltage of the ERB sensor. 
Figure 3.10 shows the average peak to peak voltage calculated at six different oscillation 
frequencies and it emphasizes that the variation of the average peak to peak voltage is 
negligible when the ERB is expanded/contracted with a frequency ranging between 0.05 Hz 
to 2.23 Hz. 
 
Figure 3.10. Average peak to peak voltage plotted versus frequency at which the ERB is expanded/contracted. 
The points which were actually measured are marked as red. 
3.3.6 Comparison to Rotary Encoder 
The spring potentiometer was also compared to the rotary encoder. Although the exploited 
reference sensor (SP) in this work is commercially sold as a linear displacement sensor, we 
further validated its linearity by comparing two hundred SP recordings with the sinusoidal 
wave interpolated using the rotary encoder data. The comparison illustrated that the average 
of two hundred SP recordings differ slightly from the interpolated wave from the rotary 
encoder. Figure 3.11 presents the sinusoidal wave derived from the rotary encoder data with 
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maximum error bars from at 30° steps in an interval of 0°to 360°. Although it was intended to 
have the expansions/contractions of the two sensors at a constant speed during the whole 
experiment, our rotary encoder data shows that the speed of the motor changed slightly from 
one recording to another. Table 3.3 summarizes the speed variations of the motor during the 
data acquisition. Nonetheless as the comparisons of interest were between the ERB and SP, 
the assessment of these remains valid. 
 
Figure 3.11. Blue refers to normalized interpolated sinusoidal wave derived from the rotary encoder data. Red 
refers to average of 200 SP recordings. The error bar at each point refers to the maximum difference of the SP 
recordings from the interpolated wave at that point. Maximum upper error is 15.8% and maximum lower error is 
17.45%. 
Table 3. 3. Statistical parameters of motor speed. 
Experiment Min Max Mean SD 
1 8.33 rpm 8.93 rpm 8.62 rpm 0.10 rpm 
2 8.56 rpm 9.32 rpm 8.97 rpm 0.15 rpm 
3 8.67 rpm 9.37 rpm 8.95 rpm 0.13 rpm 





This work has highlighted a number of important factors that will impact the use of ERB’s in 
wearable devices for accurate measurement of blood volume changes or other bio-signals 
such as respiration. Primarily, it is evident that the response during expansion and contraction 
are not the same and substantial nonlinearities exist. Secondly, the presence of baseline drift 
during the first 40 hours exists; however, this disappears with time hence may be obscured 
during use. 
The ERB sensors consist of conductive fibers coupled to each other. When the sensor is 
stretched, these fibers decouple, leading to an increase in impedance. A linear stretch-
impedance response would require conductive fiber decoupling (and recoupling) to be linear 
with stretch. It is likely that this is not the case and difference in the rate of 
coupling/recoupling of fibers is further responsible for the discrepancy in impedance 
response during stretch and relaxation. Furthermore, the baseline shift over time is likely due 
to the creation of micro-cracks in the ERB material when first used [197]. The results shown 
in Figure 3.6 suggest that once the material is repetitively strained over a period of time the 
baseline stabilizes substantially. 
The non-linear behaviour of these ERB’s does not exclude their use in the proposed medical 
applications, but it may need to be accounted for using some transfer function. The difficulty 
here is the stability of the non-linearity, which would need to be consistent over time for the 
transfer function to be accurately applied. Should a unique transfer function be required for 
each sensor then the process may become quite a burden if translated to a commercial device. 
Similarly, the baseline drift observed may require the ERBs to be cycled in a rig similar to the 
one described here in order to achieve a stable response. Of note, generally, the nonlinearity 
of the sensor is not a major impediment as a careful calibration procedure can accommodate 
all nonlinearities simultaneously. 
A number of limitations of this work are evident. Primarily, the rig could be improved as it 
exhibited minute vibration in both the ERB and SP recording during stretch/relaxation. These 
appear to be largely due to physical vibration of the sensors and movement of the pulleys 
over time. However, this rig was sufficient to highlight high-level observations of 
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nonlinearities. Future work will focus on developing a new, more accurate and reliable 
system for these purposes and establishing if nonlinear behaviour at all frequencies and 
lengths of stretch may be removed using a single transfer function. 
3.5 Conclusions 
An expansion/contraction simulator machine was developed to investigate the characteristics 
of commercially available Electro-Resistive Band (ERB) sensors. The previous chapter 
showed that ERBs could be exploited as wearable sensors for measuring blood volume 
changes in the leg. To assess the linearity/nonlinearity behaviour of the ERBs, the ERB 
sensor and a linear displacement sensor (string potentiometer) were expanded/contracted 
simultaneously. The nonlinear response of the ERBs appeared as a notch on its voltage 
output, and comparison between THD values of the ERBs and the string potentiometer 
quantified the observed nonlinearity of the ERBs. Further analysis of the ERBs data found 
decreased SNR values compared to that derived for the spring potentiometer.  
However, it should be noted that according to the hysteresis analysis shown in this chapter, 
the nonlinear behaviour of the ERB sensor would not affect the HeMo recordings, as the 
stretch experienced by ERB in HeMo is very small. In other words, the HeMo data would be 
legitimate without the need for compensation as the amount of strain of ERBs small enough 
so that the nonlinear behaviour of the ERB for this application would be negligible. It was 
also important to find that the peak-to-peak voltage of the ERB is stable for different 
frequencies. Additionally, the initial drift observed in their peak-to-peak voltage output of the 
ERBs may require the ERBs to be cycled before their use to achieve a stable response. Of 
note, the findings in this chapter impact on future validation of HeMo as the obtained 
information are parts of the validation process and feed forward to design inputs for the next 
stage of HeMo development.  
The quantification of the ERBs presented in this chapter is a starting point in the development 
of compensating mechanisms for the nonlinear behaviour of ERBs where required. The 
results of this characterisation may be of interest of other users and uses of the ERB sensors. 
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Additionally, the method presented for characterisation of the ERB sensors could be used to 




Chapter 4 Utility of HeMo for the Assessment of 
Peripheral Venous Function 
This chapter describes a simultaneous comparison of HeMo and Light Reflection 




4.1.1 Chronic Venous Insufficiency 
The peripheral venous system incorporates an interconnected network of superficial, deep 
and perforating veins and a series of valves responsible for collecting and returning oxygen-
poor blood to the heart [8]. The superficial veins are located above the muscular fascial layer, 
and are connected to the deep venous system located below the muscular fascial layer via 
perforating veins [8]. The superficial veins have a primary role in collecting deoxygenated 
blood, returning the blood to the deep venous system. Muscles in the deep venous system 
help to pump the blood back to the heart, while the valves prevent the return of blood towards 
the feet.  
Chronic venous insufficiency (CVI) is a condition, characterised by peripheral venous system 
failure and can cause pathological manifestations such as pain, itching, edema, cramps, skin 
change, swelling, and venous ulcers [8,87]. Despite the impact of CVI on an individual’s 
quality of life and the resultant financial burden on healthcare systems, CVI is often 
overlooked in primary care [7,8,22]. Several invasive and non-invasive methods (fully 
described in the first chapter) have been developed to assist in the diagnosis of CVI. One 
such method, which HeMo is capable of performing, is to measure venous filling time.  
4.1.2 Venous Filling Time (VFT) 
Venous filling time is defined as the required time for the venous volume to reach a steady 
baseline after completion of an exercise [54,67,182,193,214] and is highly correlated with 
foot vein pressure recovery time, which requires the use of invasive measurements [55]. 
More accurately, VFT is the time taken from the beginning of post-exercise relaxation until 
the venous volume reaches an endpoint which is stable for at least five seconds [51]. A 
typical VFT recording is depicted in Figure 4.1.  
Normally, contraction of the calf muscle pump empties blood out of the venous system and 
results in an immediate reduction in venous pressure. Relaxation of the muscle pump allows 
 
 75 
refilling of the venous system via arterial inflow. With valvular dysfunction, refilling of the 
venous system occurs as a result of both arterial inflow and the retrograde venous flow [8]. 
Therefore, the refill time will decrease in the presence of CVI. In other words, a shortened 
venous filling time represents venous incompetence [45,67,103,182,214,215]. 
 
Figure 4.1. A typical venous filling curve. (a): the resting value, (b): the lowest point after exercise, (c): the final 
refilling. 
There is a lack of consensus agreement for VFT threshold value, as a variety of threshold 
values have been reported (11s [64], 18s [67,103], 19s [67], 20s [54,55,59,87,182], 23s [67] 
and 25s [51,87]) to detect/exclude venous reflux.  
It should be noted that instead of VFT, other parameters such as half refilling time, 90% 
refilling time, 95% refilling time and the venous filling index could be used for the 
assessment of venous function [45,54,55,80,87,182,215–217]. Half refilling time is defined 
as the required time for the venous volume to reach fifty percent of its final volume, and 90% 
and 95% refilling time are similarly described. The Venous Filling Index (VFI) is measured 




We previously pilot tested HeMo with a single subject and demonstrated the capability of 
HeMo to measure venous filling time (chapter 2). In this chapter, HeMo VFT measurements 
are compared against the VFT values measured simultaneously from an established device in 
a well-powered study. The hypothesis being tested is that there is agreement between HeMo 
and LRR VFT measurements in healthy subjects. 
4.2 Methods 
4.2.1 Subjects 
Thirty-six subjects were recruited (Age 32.53±10.03, Female = 10). All subjects were 
healthy volunteers with no history of seizures or fainting, cardiovascular disease, chronic 
venous insufficiency, epilepsy, deep vein thrombosis (DVT), pulmonary embolism or other 
clotting problems. This study was approved by the Human Research Ethics Committee of 
Western Sydney University (Approval No: H11268). All subjects were provided with a 
participant information sheet, and they gave their written consent to participate in the study. 
4.2.2 Experimental Settings and Measurement Protocol  
All volunteers were asked to participate in the experiment wearing shorts and barefoot. 
Weight and height of all subjects were measured before the experiment setup, and date of 
birth was noted. The right leg was examined using HeMo and LRR in all cases. 
HeMo was worn on the middle calf (thickest part of the calf). The LRR sensor (VasoScreen 
5000, Medis Medizinische Messtechnik GmbH, Ilmenau, Germany) was then attached to the 
inner side of the same leg, 10 cm above the malleolus as described in the LRR device 
manual. This positioning was optimal for recordings from HeMo and the LRR sensor and it 
also allowed simultaneous venous filling time measurement with the two sensors at a 
minimum distance from each other. Each subject was requested to sit on a chair with the foot 
relaxed on the floor such that the knee created an angle of about 110 degrees with the chair 
seat (Figure 4.2). 
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The participants were instructed to follow an audible metronome generated by the 
VasoScreen device and perform ten consecutive dorsiflexion manoeuvres in a timeframe of 
20 seconds. To reduce the likelihood of signal artefacts, participants were asked to breathe 
normally and refrain from talking or moving during the experiment which included the pre-
exercise, exercise, and post-exercise periods. Venous filling traces were recorded 
simultaneously from HeMo and the LRR sensor. The experiment was repeated three times for 
each subject. Table 4.1 shows a summary of our measurement protocol for VFT measurement 
with HeMo and the LRR sensor: 
Table 4. 1. Summary of VFT measurement protocol with HeMo and the LRR sensor. 
Step Task 
1 
Ask the subject to sit on a chair with the knee flexed at approximately 110-degree angle and the foot 
relaxed on the floor. 
2 Place HeMo around the middle calf of right leg 
3 Place LRR sensor on the inner side of the same leg and about 10 cm above malleolus 
4 Start Recording and continue recording with no manoeuvres for at least 10 seconds 
5 
Ask the participant to perform ten consecutive dorsiflexion manoeuvres synchronous with metronome 
audio 
6 
Continue recording after the exercise while the subject is asked to breathe normally and to avoid 
moving and talking, until refilling is complete. 
7 Repeat steps 4, 5 and 6 for two more times.  
 
To investigate the effect of activity on venous refilling time, ten of the recruited participants 
underwent an extended version of the experiment explained above. These ten subjects were 
asked to walk on a treadmill at a self-selected pace that they considered fast walking. Once 
they selected their walking speed, they were asked to continue walking for 5 minutes. Both 
HeMo and the LRR sensor remained attached during the walking phase of the experiment. 
Subjects sat immediately after completion of the 5-minute walk. The same VFT measurement 




4.2.3 Data Acquisition  
Data from HeMo were acquired using a PowerLab data acquisition unit and LabChart 
software (AD Instruments Pty Ltd, Dunedin, New Zealand). LRR data were recorded with the 
inbuilt data acquisition unit of the VasoScreen device and associated VascularLab software. 
HeMo sampling rate was 1kHz while the VasoScreen device had a sampling rate of 224Hz. 
Both PowerLab and VasoScreen devices were connected to a laptop via USB. 
HeMo recordings were exported from LabChart to “.mat” format. The data from the LRR 
sensor was saved via VascularLab in a format, which could be only opened with 
VascularLab.  Screenshots of the LRR recordings were converted to an image type dataset for 
further analysis.  
4.2.4 Data Analysis 
Although the VascularLab software automatically measured the VFT of LRR recorded 
venous filling traces, these measurements were not necessarily correct as the software could 
not detect the starting point or in most cases the endpoint of the venous filling accurately. The 
VasoScreen device manual noted this issue and suggested manual editing of the auto-selected 
start and end points of venous refilling. 
To ensure fair comparison between devices, we developed a custom Graphic User Interface 
(GUI), which enabled importing of the LRR and HeMo datasets and manual selection of the 
venous refilling start and end points. The resulting VFT measurements were automatically 
calculated and saved based on the selection of these points. Using this GUI, all venous filling 
traces recorded by the LRR sensor were imported, opened in the GUI window one by one 




Figure 4.2. Illustration of the VFT GUI when the LRR data is opened. User selected start and end points are 
marked with blue crosses. 
 
Imported HeMo VFT traces underwent a 50th order software non-causal (zero phase lag) IIR 
low-pass filter designed using MATLAB with a cut-off frequency of 10 Hz to eliminate high 
frequency noise. Filtered HeMo data were then opened one by one, and annotated in a similar 
manner to the LRR data. An example HeMo recording opened in the GUI window is shown 





Figure 4.3. VFT GUI when HeMo data is opened. User selected start and end points are marked with blue 
crosses. 
Manual annotation could vary between raters. To assess inter-rater reliability, three 
individuals were asked to independently annotate the recordings. Each rater was asked to use 
the developed VFT GUI and mark the starting point and the endpoint of refilling for all 
HeMo and LRR recordings. 
4.2.5 Data Comparison 
A VFT threshold value of 25 seconds was used for two reasons: first, this is a strict threshold 
for healthy subjects; second, this threshold was recommended by the VasoScreen Device’s 
manual. As a cursory comparison we determined if both HeMo and LRR similarly categorise 
the study participant. Of note, as all subjects were healthy and without any diagnosed 
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peripheral vascular condition; we anticipated that all subject would be classed as not having 
venous reflux. 
Summary statistics including minimum, maximum, quartiles, mean, and standard deviation of 
VFT are calculated for both HeMo and LRR recordings. HeMo and LRR VFT measurements 
were correlated to establish the strength of connection between the two methods. Scatter plots 
and box-whisker plots of the measured VFT values are presented to visualize the relationship 
and difference between VFT measurements with the two methods. Paired t-tests are 
performed to determine if statistically significant differences exist between HeMo and LRR 
VFT values. A p value < 0.05 was considered as a statistically significant difference. Bland-
Altman plots are used to evaluate the agreement between individual HeMo and LRR 
measurements.  
Intra-class correlation analyses were also applied to investigate the inter-rater reliability of 
the VFT measurements from the three raters. The repeatability of HeMo and LRR were also 
assessed by calculating the intra-class correlation coefficient of the VFT measurements. 
Finally, to investigate the effect of the five minute walk on VFT measurements, we compared 
VFT values from before and after walking. In this comparison we used the mean value of the 
three ratings for each measurement. All statistical analyses were performed using R studio 
software (version 3.2.1).  
4.3 Results 
Venous filling traces were collected from thirty-six healthy volunteers (Female = 10) with 
HeMo and the LRR sensors simultaneously. All recorded data were included in the analysis. 
Table 4.2 presents a summary of the study population demographics. 
Given the three recordings from each participant and three annotations for each trace, our 
VFT dataset includes 324 VFT values for HeMo and 324 for LRR. Of note, recording time 
for the LRR sensor was limited to 60 seconds by the manufacturer. Therefore, all VFT values 
larger than 60 were rounded to 60. 
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Table 4. 2. Demographics of study population. 
Number of Subjects 
(Female/Male) 










36 (10/26) 79.4 (49-129) 
172.4 (150-
193) 
26.5 (18.2-40.2) 32.5 (18-56) 
 
4.3.1 Subject Classification 
Using a VFT of 25 seconds as decision threshold to identify venous reflux, HeMo and LRR 
were compared. The average of the three ratings for each recording was used for analysis. 
Using this 25 second cut-off, all 108 LRR recordings (36 subjects x 3 VFT measurements 
each calculated by averaging the three ratings) were found without venous reflux. This 
finding was expected, as the data were recorded from a healthy population. Similarly, none of 
108 HeMo recordings showed venous reflux. Therefore, the decision of HeMo and LRR 
matched for all recordings. Figure 4.4 illustrates that all VFT values for both HeMo and LRR 
are located above the VFT threshold. 
Figure 4.4. Threshold based comparison LRR and HeMo VFT values. 
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4.3.2 Comparison of Devices 
A direct comparison of the VFT values measured with LRR and HeMo. Figure 4.5 illustrates 
the average HeMo VFT measurements versus the average LRR VFT measurements. It should 
be noted that in this comparison the average of the three ratings was used for each recording.  
Correlation coefficients were calculated to examine how strongly the LRR and HeMo VFT 
measurements are related. A moderate correlation (0.47) was found between the two 
methods.  
Figure 4.5. Scatter plot of HeMo VFT measurements vs. LRR VFT measurements. Each dot corresponds to the 
average of the three ratings for a VFT recording. 
Table 4.3 demonstrates a statistical summary of the HeMo and LRR VFT measurements 
(each averaged on the three ratings for each recording). Figure 4.6 provides box-whisker 
plots of LRR and HeMo VFT measurements to visualize the presented statistical summary by 














LRR 29.45 47.22 51.53 49.72 54.06 60.00 6.23 
HeMo 36.38 48.51 51.60 51.38 55.60 60.00 5.73 
 
 
Figure 4.6. Box-whisker plots of LRR and HeMo VFT measurements. The horizontal line within the box 
indicates the median. The bottom and top edges of the box represent the lower (25%) and upper (75%) quartiles. 
The whiskers of the diagram show the range for each group of VFT data. P value: 0.01; mean difference: -1.66. 
A paired t-test of LRR and HeMo VFT measurements revealed a significant difference 
between the two devices (p = 0.01), with HeMo having longer VFT’s (1.66 seconds on 
average) when compared to LRR.  
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Agreement between the two methods is graphically presented with Bland-Altman plots in 
Figure 4.7, where the difference is plotted against the mean of the two measurements. The 
systematic error is presented by the bias (mean difference of the two measurements) and the 
limit of the agreement is displayed by the upper (bias+2SD) and lower (bias-2SD) limits.   
 
Figure 4.7. Bland-Altman plots of differences between LRR and HeMo VFT measurements versus their mean 
values. Horizontal lines from top to bottom represent upper limit, bias and lower limit. 
 
Table 4.4 summarizes the systematic error and limits of agreement corresponding to the 
presented Bland-Altman plots. 
Table 4.4. Summary of the statistics in Bland Altman plots of HeMo and LRR VFT measurements. 









As can be seen in Figure 4.7, there is small negative bias showing that the LRR 
measurements are on average lower than HeMo measurements. Difference points tend to 
follow an almost normal distribution and 96% of the data points lie within the limits of 
agreement. Additionally, the difference of the two measurements does not vary with the 
average values in any significant way highlighting the normality of mean differences. 
The limits of agreement are quite wide, raising a question about the degree of agreement 
between the two measurements. As we showed earlier, all measurements agree in deciding 
whether or not the subject is healthy. However, we cannot yet make any general claims about 
the overall agreement of the two devices in patient groups, as this was not the hypothesis 
under test. 
4.3.3 Inter-rater Reliability of the Annotations 
Three raters independently marked the start and end points of each venous refilling trace. To 
assess the inter-rater reliability of the three annotations, their intra-class correlation 
coefficients and 95% confidence intervals were calculated (Table 4.6). 
Table 4.5. Inter-rater reliability of annotations. 
Method 
Intra-Class Correlation of 
Annotations 
95% Confidence Interval  
LRR 0.55 0.45 < ICC < 0.65 
HeMo 0.39 0.27 < ICC < 0.51 
 
Figures 4.8 and 4.9 visualize the inter-rater reliability of the three annotations for LRR and 
HeMo. Comparison of mean and quartiles for each annotation are given in Figure 4.10, where 




Figure 4.8. LRR annotations for all measurements.  
 
 








Figure 4.10. Box-whisker plots of the three annotations for LRR and HeMo. 
As can be seen in above figures, there is clearly an inter-rater reliability issue for both LRR 
and HeMo measurements.  
4.3.4 Repeatability of the HeMo and LRR measurements  
As the LRR and HeMo recordings were repeated three times for each subject, we were able 
to assess the repeatability of VFT measurement for each device. The average of three 
annotations was used for each recording and calculated the intra-class correlation coefficient 
of the three measurements from each subject (Table 4.6). Figures 4.11 and 4.12 visualize the 
repeatability of the three measurements for LRR and HeMo. Comparison of mean and 
quartiles for each measurement are given in Figure 4.13 where box-whisker plots of the three 
measurements for both LRR and HeMo are illustrated. 
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Table 4.6. Repeatability of measurements. 
Method 




for ICC Population Values 
LRR 0.72 0.57< ICC < 0.84 
HeMo 0.33 0.13< ICC < 0.55 
 
Figure 4.11. LRR measurements for each subject. Values are mean of annotated values. 
 





Figure 4.13. Box-whisker plots of the three measurements for LRR and HeMo. 
 
4.3.5 Effect of Five Minute Walk on VFT  
Ten of the recruited participants underwent an extended version of the experiment, which 
included three VFT measurements, a five minute walk at a self-selected “fast” speed and a 
repeat of three VFT measurements. Similar to the previously presented data, three raters 
marked the start and end points of the venous refilling traces recorded from these ten 
subjects. The average of the nine VFT values (three measurements each annotated by three 
raters) was used for each recording.  
Figure 4.14 a shows LRR VFT values measured before and after the five-minute walk and 
Figure 4.15 b provides a similar illustration for HeMo measurements. The mean and standard 





Figure 4.14.  Comparison of before and after walk VFT measurements. Panel (a) refers to LRR measurements; 
Panel (b) refers to HeMo measurements. 
Comparison of these two figures infers a better agreement between before and after exercise 
VFT values for HeMo. To further investigate the legitimacy of the recent cursory conclusion 
from Figure 4.14 We did a paired t-test between before and after walk VFT measurements for 
both HeMo and PPG (Table 4.7).  

























































* Denotes the p value from paired t-test of before and after walk VFT measurements. 
The results from paired t-test further highlighted more robustness of HeMo VFT 
measurements to exercise compared to the LRR VFT measurements.  
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The box-whisker plots of before/after exercise VFT measurements for HeMo and LRR in 
Figure 4.15 illustrates a smaller difference of before/after exercise VFT for HeMo 
measurements compared to the difference for LRR measurements.  
 
Figure 4.15. Box-whisker plots of before and after exercise VFT measurements. Panel (a) refers to LRR VFT 
measurements; Panel (b) refers to HeMo VFT measurements. 
4.4 Discussion and Conclusion 
Chronic venous insufficiency is a common condition, which can lead to loss of limb or 
venous ulcers demanding prolonged therapy. Venous Filling Time (VFT) was measured in 
thirty-six healthy volunteers using HeMo and a Light Reflection Rheography (LRR) sensor 
simultaneously. Qualitative comparison of the two measurements revealed similar results, 
with all subjects classified as healthy based on a threshold VFT of 25 seconds, the borderline 
selected to distinguish healthy and unhealthy venous systems. 
Quantitative comparison of VFT measurements from the two sensors showed only a 
moderate correlation (r=0.47) with a mean difference of -1.66. A paired t-test of the two 
measurements highlights a systematic difference between HeMo and the LRR sensor 
(p = 0.01). However, this does not mean one measurement is wrong; LRR is sensitive to only 
one area of skin whereas HeMo effectively examines the entire part of the leg it encloses. 
Bland-Altman plots of HeMo and LRR VFT values demonstrated a small mean bias, 96% of 
the difference-points within limits of agreement and with a distribution tending to normal. 
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Limits of agreement were wide, but acceptable for the presented dataset, as it did not affect 
the decisions of HeMo in classifying a subject as healthy/unhealthy.  
The moderate correlation coefficient between devices and the statistical significance 
difference found between them can be attributed to a variety of factors. The HeMo 
measurement area on the leg was different from the LRR sensor location. Further, HeMo uses 
electro-resistive polymer sensors and measures blood volume changes of the area on the leg 
inscribed by the cuff, whereas, the LRR uses optical-based sensor and measures the amount 
of blood volume variation underneath the area of skin where the LRR sensor is placed. 
Both LRR and HeMo suffer from repeatability and inter-rater reliability issues. As the 
experiment is quite short, it is feasible to take the mean of multiple measures as we have done 
here and ameliorate the repeatability issue to some degree. The inter-rater reliability problem 
is more difficult to solve. Automated computer selection of the start and end points may be 
the most effective means of ensuring a reliable reproducible measure, as even with extensive 
instruction the raters were quite different at times. 
It should also be noted that the reference method in this experiment is not the gold standard 
method for venous assessment. This is one of the major limitations of the presented study and 
comparison of HeMo with the gold standard should be applied in future validation steps of 
this prototype. Of course, HeMo needs to be studied in clinical settings extending our current 
VFT dataset to one including both control and patient subjects to define the optimal 
threshold/ranges to separate healthy and CVI limbs.  
This chapter demonstrates acceptable agreement between HeMo and LRR for healthy 
population. However, it should be noted that HeMo needs improvements in terms of its 
reliability and of course it needs to be tested in clinical settings against the gold standard for 
further validation. Although the LRR sensor is cheaper and requires less time and technical 
skills compared to the gold standard (Duplex Ultrasound) used for venous assessment, HeMo 
is vastly less expensive by two orders of magnitude and needs less training, which potentially 
may lead to its widespread use. The results of the exercise experiment showed that HeMo 
was quite robust to activity, which may eliminate the need for pre-test rest and consequently 
reduces the required time for diagnosis. Overall, the results suggest that HeMo has good 
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potential for assessing venous function in the leg. This technology may serve as an important 




Chapter 5 Evaluation of HeMo for the Assessment 
of Arterial Function 
This chapter provides a comparison of HeMo and Photoplethysmography (PPG) arterial pulse 




5.1.1 Peripheral Arterial Disease (PAD) 
Peripheral arteries are responsible for carrying oxygen-rich blood from the heart to the limbs. 
The failure of one or more arteries decreases blood flow to the limbs and ultimately, it may 
lead to morbidity/mortality [4,117,219]. Incompetence of the peripheral arteries is known as 
peripheral arterial disease (PAD), a condition in which one or more peripheral arteries 
become narrowed or blocked due to the plaque development in the arteries [220,221]. The 
most common risk factors for PAD are age, male gender, diabetes, smoking, dyslipidemia 
(high level of fat in blood), and hypertension [142,222]. PAD is highly prevalent, affecting 
10-15% of general population and often underdiagnosed, up to 50% of patients with PAD are 
asymptomatic [16,66,114,154]. Symptomatic PAD can present with pain at rest, intermittent 
claudication, skin changes, ischemic ulceration and gangrene [14,147,223]. Both 
symptomatic and asymptomatic patients with PAD are at high risk of cerebrovascular and 
cardiovascular events [14,16,28,122,223]. Therefore, a routine screening test is required for 
risk factor modification and effective treatment which can lead to decreased clinical events, 
lessen the progression to limb loss, prevent disability/death, and in general to improve quality 
of life [16]. Various established diagnostic tests (fully described in Chapter 1) have been used 
for the assessment of arterial perfusion in the leg. The arterial pulse wave has been commonly 
used for the assessment of arterial perfusion as the arterial pulse becomes distorted in the 
presence of PAD, appearing damped, delayed and diminished. 
5.1.2 Arterial Pulse Wave (APW) 
Arterial Pulse Wave (APW) analysis is a non-invasive method to evaluate arterial blood flow 
and identify peripheral arterial insufficiency in the lower limbs. The arterial pulse signal 
shows the variation in blood flow with each heartbeat that goes from the heart to the limbs 
with a wave-like pattern [48]. The APW can be separated into to three main components 
which, correspond to different phases of a cardiac cycle (Figure 5.1): a steep upstroke and 
sharp peak occurring during systole (anacrotic phase), the dicrotic notch (reflective wave) 
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representing the closure of aortic valve, and a gradual downslope occurring during diastole 
(catacrotic phase) [192]. 
 
Figure 5.1. A typical arterial pulse waveform. (a) systolic peak, (b) dicrotic notch and (c) diastolic peak. 
 
Qualitative Interpretation of the Arterial Waveform 
Normally, the APW appears with a dicrotic notch on the catacrotic phase and the pulse 
becomes delayed, distorted and diminished in the presence of PAD [52,192,224]. The 
amplitude of the systolic peak and the shape of the APW are two key aspects, which are 
commonly considered for a qualitative interpretation of the arterial waveform [185,192]. The 
disappearance of the dicrotic notch often represents arterial obstruction, while reduced 
systolic amplitude shows poor local perfusion [185,192]. Qualitative interpretation of the 
APW is simply done by visually comparing the APW to a four-level grading system (Figure 
5.2), which enables the classification of the APW as normal, mild PAD, moderate PAD, and 




Figure 5.2. Arterial pulse wave grading system [192]. Grade A is attributed to an APW with a prominent 
dicrotic notch and sharp systolic peak; Grade B is attributed to an APW in which the dicrotic notch is 
disappeared; Grade C is attributed to an APW in which the dicrotic notch is absent, the systolic peak is flattened, 
the upslope and downslope time are decreased and almost equal; Grade D is when the amplitude of pulse is 
significantly decreased, upslope and downslope times are equal or there is absence of the pulse. 
 
Quantitative Interpretation of the Arterial Waveform 
Quantitative interpretation of the APW involves extracting various pulse characteristics such 
as systolic amplitude, rise time/crest time and half pulse width. 
Systolic amplitude represents blood volume changes due to arterial inflow around the 
measurement site [48,226,227]. Patients with PAD usually have reduced systolic amplitude 
which can be attributed to blood volume decrease in the microvascular bed resulting from 
blood pressure reduction across a stenosis [52,228,229].  
Crest time or foot-to-peak rise time is defined as the time from the beginning of the APW to 
its systolic amplitude (Figure 5.3) and has proven to be a useful feature in diagnosis of PAD 
[48,52]. Delayed rise time is expected in the presence of PAD due to increased vascular 
resistance and reduced blood pressure as a result of stenosis [52]. 
Half pulse width is the width of APW at its half height. As the systolic peak reduces and the 
APW becomes damped with PAD, the half pulse width is expected to become wider. Awad et 
al. found a positive correlation between the half pulse width and vascular resistance 
suggesting that the half pulse width is increased with the severity of PAD [230]. It should be 
also noted that the presence/absence of the dicrotic notch can be investigated by searching for 
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the inflection point of the APW. The inflection point may be difficult to be found in some 
APW recordings. However, the first derivative of the APW is helpful as the inflection point 
appears as a local maximum on the derivative of the APW [48]. 
 
Figure 5.3. Illustration of crest time/rise time. 
 
Figure 5.4. Illustration of half pulse width. 
Other features of APW such as pulse interval/pulse width, augmentation index and large 
artery stiffness index (Figure 5.7) can be also extracted from arterial pulse signals and 
provide meaningful information [48].  
Pulse interval or pulse width is the time between the beginning and the end of the APW 
(distance between two consecutive APW minimums) (Figure 5.5) [48].  
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Augmentation index is measured by dividing the amplitude of diastolic peak (y) by the 
amplitude of systolic peak (x) (Figure 5.6): 
                                                      Augmentation index = !
!
                                             (5.1) 
 
Figure 5.5. APW pulse width 
 
Figure 5.6. Illustration of x and y for calculation of augmentation index. x is amplitude of systolic peak and y is 
amplitude of diastolic peak. 
 
Large artery stiffness index is defined as the ratio of patients’ height to the time interval 




                                  Stiffness index = !"#$%& !" !"#$%&'
!"#$%&'( !"#$ !" !"#$%&'"( !"#$ !"#$
                        (5.2) 
 
Figure 5.7. Systolic peak to diastolic peak time for calculation of stiffness index. 
It is not yet known if these three APW features (pulse width, augmentation index and 
stiffness index) can reveal information about the presence/absence of PAD. However, each of 
the mentioned features has been proven to have other diagnostic values. For example, pulse 
interval represents a complete heart cycle and could be used to monitor heart rate variability 
[48,231–234]. Augmentation index and large artery stiffness index have been reported to be 
useful for the assessment of arterial elasticity [48,235]. Additionally, the second derivative of 
the APW have been reported as a potential candidate for assessment of arterial distensibility 
[48,236,237].  
Other features including three quarters pulse width (Figure 5.8) and dicrotic notch to diastolic 
peak time (Figure 5.9) can be also extracted from the APW. However, no study has assessed 
their diagnostic value as of yet. 
We previously examined the use of HeMo in a single subject and showed the capability of the 
device to record arterial pulse waves (chapter 2). In this chapter we expand on this prior 
work, determining if APW metrics as described may be extracted. We further compare these 
parameters to arterial pulses recorded from an established device in a well-powered study. 






Figure 5.8.Three quarters pulse width. 
 
Figure 5.9. Dicrotic notch to diastolic peak time 
5.2 Methods 
5.2.1 Subjects 
Thirty-six healthy volunteers aged 18-65 were recruited for this study. None of the 
participants had a history of seizures or fainting, cardiovascular disease, chronic venous 
insufficiency, epilepsy, deep vein thrombosis (DVT), pulmonary embolism or other clotting 
problems. All data were recorded from the right leg. This study was approved by the Human 
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Research Ethics Committee of Western Sydney University (Approval No: H11268). All 
subjects gave their written informed consent prior to their participation in the study. 
5.2.2 Experimental Settings and Measurement protocol  
All subjects participated in the experiment wearing shorts and barefoot. Height, weight, and 
age of each participant were recorded. Volunteers were asked to wear HeMo on the thickest 
part of the calf and the PPG sensor (VasoScreen 5000, Medis Medizinische Messtechnik 
GmbH, Ilmenau, Germany) was placed on the great toe. Each subject was then asked to sit on 
a chair with the foot relaxed on the floor. Participants were asked to refrain from talking or 
moving and asked to breath normally during the experiment to protect the arterial pulse signal 
from possible artefacts. 
Recordings were made simultaneously from both HeMo and the PPG sensor. To synchronize 
data from the two devices, we asked each participant to perform a single dorsiflexion 
manoeuvre. The dorsiflexion manoeuvre induced artefact on both recordings providing a 
marker to synchronize the recordings. Two minutes of data were captured in each instance 
and participants were asked to perform an additional dorsiflexion to mark the end of the 
recording. Table 5.1 summarises the experiment protocol. 
Table 5.1. Summary of APW recording protocol for HeMo and PPG sensor. 
Step Task 
1 Ask the subject to sit on a chair with the foot relaxed on the floor. 
2 Place HeMo around the middle calf of right leg. 
3 Place PPG sensor on the big toe of the same leg. 
4 Start Recording  
5 Ask the participant to perform one dorsiflexion manoeuvre and continue recording for two minutes. 
6 Ask the participant to perform one dorsiflexion manoeuvre and stop the recording. 
 
An extended version of the experiment was conducted to investigate the effect of activity on 
the arterial pulse wave. In this experiment, ten of the thirty-six volunteers were asked to rest 
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while sitting on a chair for fifteen minutes before the experiment to protect the phase one of 
the APW recording from the effect of walking before the trial. A complete version of the 
APW experiment (as explained above) was then conducted, and APW was recorded.  The 
experiment continued by asking the subjects to walk on a treadmill with the HeMo cuff on 
their leg and with a speed at which they could consider fast walking. Of note, the PPG sensor 
had to be taken off for this phase of the experiment. Once the participant selected their 
preferred walking speed, they continued walking for five minutes. The subjects were asked to 
sit immediately following completion of the 5-minute walk and the PPG sensor was then 
reattached on the great toe for the second phase of APW recording. The same APW recording 
experiment was then repeated. 
5.2.3 Data Acquisition  
HeMo APW data were recorded with a sampling rate of 1kHz using a PowerLab data 
acquisition unit and LabChart software (AD Instruments Pty Ltd, Dunedin, New Zealand). 
The PPG data were acquired with sampling rate of 224 Hz using the inbuilt data acquisition 
unit of the VasoScreen device and VascularLab software. The AD instrument box and 
Vasoscreen device were both connected to a laptop via USB. 
HeMo APW traces were exported from LabChart to “.mat” format. PPG APW data were 
saved with Vascularlab software, exported in “. csv” format and imported into MATLAB for 
further analysis. 
5.2.4 Data Analysis 
All HeMo APW recordings underwent a 50th order software non-causal (zero phase lag) IIR 
low-pass filter implemented using MATLAB with a cut-off frequency of 10 Hz to remove 
high frequency noise. The low-pass filtered data then underwent a Matlab 2nd order high pass 
filter with a cut-off frequency of 1.4 Hz to remove and potential baseline wander. The 
filtering steps were necessary to clean HeMo recordings and prepare them for comparison 
with the PPG data. The HeMo and PPG data were then synchronized for each subject using 
the two dorsiflexion manoeuvre markers visible on both APW recordings. Three arterial beats 
from HeMo and three corresponding arterial beats from PPG were then selected. We selected 
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APWs similarly for all participants to create a dataset including 138 HeMo and 138 PPG 
epochs.  
To facilitate the APW feature extraction and comparison of the HeMo and PPG data, we 
developed a graphic user interface (GUI). The APW GUI enabled importing of the APW 
dataset, plotting both the APW beat and its first derivative, selecting five key points (the 
starting and end points, systolic and diastolic peaks and the dicrotic notch) of each beat, and 
finally saving the coordinates of the selected points for each beat. Of note, since the dicrotic 
notch is the inflection point of APW, the first derivative of APW can assist finding the 
dicrotic notch by simply visualizing it as a local maximum (Figure 5.2). 
Using this GUI, first, all PPG APW beats were imported and opened sequentially in the GUI 
window. Figure 5.2 illustrates the GUI with an example PPG recording opened and 
annotated. 
 
Figure 5.10. APW GUI when PPG data is opened for annotation of the starting point, systolic peak, dicrotic 
notch, diastolic peak and the endpoint. User annotations are marked as crosses and colour coded. 
HeMo data annotated in a similar fashion. Figure 5.3 illustrates the GUI with an example 
HeMo recording opened in the GUI window and annotated. The complete MATLAB code of 
the APW GUI associating with the guideline for the use of this GUI is given in Appendix A. 
The APW dataset underwent a double-blind annotation. The annotator was asked to use the 
developed APW GUI and mark five points (APW start and end points, systolic and diastolic 
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peaks and the dicrotic notch) for all PPG and HeMo recordings. In total, 276 APWs were 
annotated. 
 
Figure 5.11. APW GUI when HeMo data is opened for annotation of the starting point, systolic peak, dicrotic 
notch, diastolic peak and the endpoint.  User annotations are marked as crosses and colour coded. 
5.2.5 Data Comparison 
Qualitative Comparison 
The presence/absence of the dicrotic notch was investigated in all data by visually checking 
the point of inflection, the point at where the first derivative of APW appeared with a local 
maximum. The result of the search for dicrotic notch in HeMo and PPG data were then 
compared to provide a qualitative comparison of the two sensors. 
Quantitative Comparison 
The following features were extracted from each HeMo and PPG APW - rise time, half pulse 
width, three quarters pulse width, dicrotic notch to diastolic peak time, systolic peak to 
diastolic peak time, stiffness index, augmentation index and pulse width. All of these metrics 
are explained in the introduction and are calculated simply using the annotated data points. 
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HeMo APW and PPG APW features were statistically compared using minimum, maximum, 
1st and 3rd quartiles, median, mean, standard deviation, and confidence intervals. Box-whisker 
plots of HeMo and PPG features were used to compare the distribution of each feature for the 
two methods. Correlation coefficients were calculated for each APW feature of HeMo and 
PPG to assess the strength of the relationship between the two measures. Paired t-tests were 
also conducted to determine if extracted APW features of HeMo and PPG differ from one 
another. A p value of <0.05 was considered as a statistically significant difference between 
both methods. 
A beat-by-beat comparison of HeMo and PPG APW features was shown using scatter plots 
to depict the differences between the APW features of the two methods. We used Bland-
Altman plots to investigate the limits of agreement for the extracted APW features. 
Given that our APW dataset included three arterial beats for each subject, we assessed the 
repeatability of each APW feature for HeMo and PPG by calculating intra-class correlation 
coefficients for each of the extracted features. 
Finally, APW features from before and after walking we extracted for participants who took 
part in the exercise study, to determine the effect, if any, of five minutes exercise on the APW 
features of HeMo and PPG. It should be noted that each APW feature was averaged over the 
three selected beats for each subject.  
All statistical analyses were performed using R studio software (version 3.2.1). 
5.3 Results 
Arterial pulse wave recordings were collected from thirty-six healthy volunteers with HeMo 
and PPG sensor simultaneously. None of the participants were excluded from the study. 
Table 5.2 provides a summary of participant demographics. 
Table 5.2. Summary of participant demographics 
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5.3.1 Qualitative Analysis and Comparison 
A cursory comparison of PPG and HeMo recordings was performed by visually inspecting 
the APW for the presence of a dicrotic notch. The dicrotic notch was seen in all 108 PPG and 
HeMo recordings. It should be noted that presence of the dicrotic notch was expected as the 
arterial pulse waves were recorded from healthy subjects. None-the-less, both HeMo and 
PPG showed agreement and classified all subjects as healthy. 
5.3.2 Quantitative Analysis and Comparison 
Population Distribution of Extracted Features 
To provide a quantitative comparison of the two methods, we compared eight features (rise 
time, half pulse width, three quarters pulse width, dicrotic notch to diastolic peak time, 
systolic peak to diastolic peak time, stiffness index, augmentation index and pulse width) of 
both PPG and HeMo arterial pulse recordings. Three APWs were averaged for each of the 36 
participants for both PPG and HeMo. 
Table 5.3 presents a statistical summary of HeMo and PPG arterial pulse features providing 
the comparison of minimum (min), maximum (max), 1st quartile (1st Qu), 3rd quartile (3rd Qu), 
mean (μ), median, standard deviation (Std) and 95% confidence interval (95% CI) of HeMo 
and PPG APW features. The correlation coefficients (CC) and p value from paired t-test 











































































































































0.744 0.815 0.817 0.881 1.102 0.098 0.032 
* Denotes the p value from paired t-test of HeMo and PPG APW features. 
 
 111 
Figure 5.12 provides box-whisker plots for the extracted APW features displaying a 







Figure 5.12. Box-Whisker plots of PPG and HeMo arterial pulse wave features. The horizontal lines in each box 
plot represent median, each box itself shows first and third quartiles, and the whiskers indicate the range.   
 
 
As can be seen in Figure 5.12 the range of values for HeMo were smaller. This indicates that 
HeMo has tighter confidence intervals and potentially a more sensitive determination of non-
healthy arterial waveforms. 
The box plot comparison of HeMo and PPG features shows that the time-based features (rise 
time, half pulse width, three quarters pulse width, dicrotic notch to diastolic peak time and 
systolic peak to diastolic peak time) extracted from HeMo form a distribution with higher 
values compared to the distribution of the same features extracted from PPG. The minimum, 
maximum and quartiles of HeMo stiffness index values are lower compared to those values 
from PPG stiffness. It is also evident that the augmentation index measurements of HeMo 
form a distribution with higher values compared to PPG. Among the extracted features pulse 
width of the two sensors tend to have a very similar distribution.  
The strong correlation found between the pulse width of the PPG and HeMo pulse width was 
expected as each arterial pulse corresponds to the heartbeat propagating as a wave through 
limbs and the arterial pulse waves of the two sensors were simultaneously recorded. The 
poor/moderate correlation of other features can be explained by difference of the contour of 
arterial pulse wave of HeMo and PPG. 
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The calculated p value for pulse width greater than 0.05 further highlights the similarity of 
pulse widths of HeMo and PPG as expected. The p values calculated for other extracted APW 
show statistically significant differences between HeMo and PPG recordings (p < 0.05). 
Contours of HeMo and PPG arterial pulse waves 
Figure 5.13 illustrates three examples of PPG and HeMo arterial pulse waves recorded for 
three subjects. Although the overall shape of APW looks similar for PPG and HeMo, we 
found that the HeMo arterial pulse recording generally look slightly damped compared to 
PPG arterial pulse recordings resulting in increased rise time values for HeMo recordings. 
The broadened shape of HeMo APW also explains the difference in time-based features such 
as half pulse width, three quarters pulse width, dicrotic notch to diastolic peak time, systolic 
peak to diastolic peak time and stiffness index. Another prominent difference is the amplitude 






Figure 5. 13. Three examples of APW recordings with PPG and HeMo from three subjects. The blue printed 
plots on the left show PPG recording and the red printed plots illustrate the APW of corresponding HeMo 
recordings. 
Beat-By-Beat Comparison of HeMo and PPG 
Since our APW dataset contains three APW beats for each participant, the APW features 
dataset contains 108 values for each of the features of PPG and HeMo. To visualize the 
relationship between the features of HeMo and PPG arterial pulse waves, we did a direct 
comparison of HeMo and PPG APW features. Figure 5.14 demonstrates features of HeMo 
plotted vs. features of PPG. The red line in each plot has a slope of one and passes through 
the point (1, 1) shown to depict how each features of the two sensors are different from each 
other.  
Figures 5.14 a, b, c, d, e indicate mainly higher values of time-based features (rise time, half 
pulse width, three quarters pulse width, dicrotic notch to diastolic peak time and systolic peak 
to diastolic peak time) for HeMo further highlighting steepening of the arterial pulse of PPG 
compared to HeMo. HeMo appears to have lower stiffness index values (Figure 5.14 f), as 
stiffness index is inversely related to systolic to diastolic peak time. Figure 5.14 g shows 
higher values of augmentation index for HeMo, which is explained by higher diastolic peak 
amplitude seen in HeMo APW recordings. Figure 5.14 h illustrates that pulse width feature 












Figure 5.14. Scatter plots of HeMo APW features vs. PPG APW features. 
 
Agreement between the APW features of HeMo and PPG are visualised used Bland-Altman 
plots, in which the mean differences of each HeMo and PPG APW features is plotted vs. their 
mean value (Figure 5.15). The bias, mean difference of the two measurements, presents the 
systematic error between two measurements, and the limits of agreement are shown with the 
upper (bias+2SD) and lower (bias-2SD) limits. Table 5.4 provides a summary of the bias, 











Figure 5.15. Bland-Altman plots of PPG and HeMo arterial pulse wave features. The dashed horizontal lines in 




Table 5.4. Summary of the statistics in Bland Altman plots of HeMo and PPG arterial pulse wave features. 
APW Feature Bias SD Lower limit Upper Limit 
Rise Time -0.069 0.032 -0.133 -0.005 
Half Pulse Width -0.121 0.129 -0.380 0.138 
Three Quarters Pulse Width -0.017 0.052 -0.121 0.087 
Dicrotic Notch to Diastolic Peak 
Time 
-0.033 0.042 -0.116 0.050 
Systolic peak to diastolic peak 
time 
-0.024 0.050 -0.124 0.075 
Stiffness Index 0.490 1.109 -1.729 2.708 
Augmentation Index -0.098 0.132 -0.362 0.167 
Pulse Width 0.001 0.035 -0.069 0.071 
 
In the presented Bland-Altman plots, at least 94.5% of data for each feature lie within their 
limits of agreement. No appreciable trend was found for any of the features except for half 
pulse width. However, due to lack of any reported threshold value for the extracted features 
we cannot make any claim on the agreement of HeMo and PPG features. This is because 
making any statement about the agreement of two variable requires the comparison of limits 
of agreement with a priori defined clinical limit criteria [238].  
It should be mentioned that Figure 5.15 b shows the absolute difference increases as the 
average of measurements increases. Moreover, there can be seen two completely separate 
local maximums on the distribution of half pulse width differences (Figure 5.15 b) further 
highlighting the jump of half pulse width values earlier discussed. This effect has resulted to 
have a wide limit of agreement for half pulse width and in practice would probably exclude it 
as a potential metric for HeMo. In contrast, a better agreement is found for three quarters 
pulse width as it has a narrower limit of agreement, a smaller bias, and the distribution of 
differences looks more similar to a normal distribution.  
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5.3.3 Repeatability of the HeMo and PPG Measurements  
We assessed the repeatability of APW features extracted from HeMo and PPG by calculating 
the intra-class correlation coefficient for each feature. Table 5.5 provides the calculated intra-
class correlation coefficients and their 95% confidence interval for the extracted features of 
HeMo and PPG arterial pulses.  
Table 5.5. Repeatability of the APW features. 
APW Feature Intra-class correlation of Measurements 95%-Confidence Interval 
Rise Time (PPG) 0.747 0.609 < ICC < 0.851 
Rise Time (HeMo) 0.479 0.282 < ICC < 0.662 
Half Pulse Width (PPG) 0.861 0.774 < ICC < 0.921 
Half Pulse Width (HeMo) 0.35 0.144 < ICC < 0.559 
Three Quarters Pulse Width 
(PPG) 
0.372 0.169 < ICC < 0.577 
Three Quarters Pulse Width 
(HeMo) 
0.188 -0.01 < ICC < 0.414 
Dicrotic Notch to Diastolic Peak 
Time (PPG) 
0.667 0.504 < ICC < 0.798 
Dicrotic Notch to Diastolic Peak 
Time (HeMo) 
0.181 -0.011 < ICC < 0.405 
Systolic peak to diastolic peak 
time (PPG) 
0.881 0.805 < ICC < 0.933 
Systolic peak to diastolic peak 
time (HeMo) 
0.209 0.008 < ICC < 0.436 
Stiffness Index (PPG) 0.854 0.764 < ICC < 0.917 
Stiffness Index (HeMo) 0.294 0.086 < ICC < 0.513 
Augmentation Index (PPG) 0.926 0.876 < ICC < 0.959 
Augmentation Index (HeMo) 0.324 0.116 < ICC < 0.538 
Pulse Width (PPG) 0.879 0.802 < ICC < 0.932 
Pulse Width (HeMo) 0.823 0.714 < ICC < 0.899 
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The calculated correlation coefficients show the arterial pulse features extracted from PPG 
are more repeatable. In contrast, low values of intra-class correlation clearly indicate a 
repeatability issue for the HeMo measurements. 
5.3.4 Effect of Five Minutes Fast Walking on APW Features 
Ten of the recruited subjects underwent an extended version of the experiment, which 
included APW recording, five minutes fast walking and re-recording of the APW. Eight 
arterial pulse wave features were extracted before/after exercise from HeMo and PPG 
recordings. Each feature was averaged over three beats for each subject.  
Figure 5.16 shows the change in each APW feature before and after exercise. Mean and 
standard deviations of both before and after walk APW features are given in Table 5.6. 
Correlation coefficients of before and after exercise features were calculated to determine 
how strongly the measurements before and after exercise are related. A paired t-test between 














Figure 5.16. Comparison of before and after walk APW features. PPG APW features are presented in blue and 
HeMo APW features are depicted in red. The mean of each feature is presented in black. 
 













Rise Time before 
Walk 
0.15 0.23 0.01 0.03 
0.04 0.66 0.84 0.33 
Rise Time after Walk 0.15 0.22 0.01 0.03 
Half Pulse Width 
before Walk 
0.19 0.35 0.03 0.09 
0.43 0.50 0.10 0.02 
Half Pulse Width 
after Walk 
0.24 0.28 0.10 0.07 
Three Quarters Pulse 
Width before Walk 
0.13 0.16 0.02 0.03 
0.35 0.15 0.33 0.31 
Three Quarters Pulse 
Width after Walk 
0.14 0.15 0.03 0.03 
Dicrotic Notch to 
Diastolic Peak Time 
before Walk 
0.13 0.17 0.02 0.03 
0.60 0.23 0.07 0.20 
Dicrotic Notch to 
Diastolic Peak Time 
after Walk 
0.14 0.15 0.02 0.03 
Systolic Peak to 
Diastolic Peak Time 
before Walk 
0.30 0.33 0.02 0.04 
0.32 0.54 0.87 0.24 
Systolic Peak to 
Diastolic Peak Time 
after Walk 
0.30 0.31 0.02 0.04 
Stiffness Index before 
Walk 
5.88 5.41 0.65 0.59 
0.77 0.57 0.99 0.22 
Stiffness Index after 
Walk 
5.88 5.68 0.41 0.76 
Augmentation Index 
before Walk 
0.38 0.51 0.08 0.07 
0.50 -0.16 0.31 0.01 
Augmentation Index 
after Walk 
0.34 0.40 0.13 0.07 
Pulse Width before 
Walk 
0.82 0.82 0.10 0.11 0.67 0.76 0.15 0.09 
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Pulse Width after 
Walk 
0.77 0.77 0.12 0.11 
 
All before and after walk APW features of PPG were not significantly different (paired t-test 
p > 0.05). The same was also the case for HeMo, except for the augmentation index which 
was significantly lower following exercise (p = 0.01).  
5.4 Discussion and Conclusion 
Peripheral Arterial Disease (PAD) is highly prevalent [2,16,17] and can lead to loss of limbs 
and/or death [2,13–15]. PAD may be symptomatic or asymptomatic, however, both groups 
are at the same risk [2,28,29]. Early diagnosis of PAD is important as it can help prevent limb 
amputation and cardiovascular events [50]. Recording arterial pulse wave (APW) and 
comparing it with a grading system is one means of screening for impaired arterial function 
[192]. While the lack of an evident dicrotic notch is an initial sign of PAD [192], some APW 
features have also shown potential in diagnosing PAD [48,52,230].  A variety of features can 
be extracted from arterial pulse signal [48,52,231–233]. However, not all APW features are 
proven to have clinical value in diagnosis of PAD. Among APW features, rise time, half 
pulse width and the amplitude of systolic peak have shown to have diagnostic value for PAD 
[48,52,230]. 
APWs from thirty-six healthy volunteers were collected with HeMo and a 
photoplethysmography sensor simultaneously to compare the HeMo arterial pulse recording 
with the APW recording of a commercially available sensor. The APW recordings of the two 
methods were visually compared and the dicrotic notch was found in all HeMo and PPG 
APW recordings. 
To provide a quantitative comparison of recordings of the two methods, eight APW features 
were extracted from HeMo and PPG arterial pulse recordings and they were statistically 
compared. The pulse width/pulse interval extracted from the APW of the two sensor were 
highly correlated (r=0.99), and their difference was not statistically significant (p = 0.62) 
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showing that HeMo can provide an estimate of heart rate similar to the PPG estimate of heart 
rate. In contrast, poor or moderate correlation was found between other APW features of 
HeMo and PPG, and their corresponding p values showed statistically significant differences 
between each pair of APW features.  
The poor/moderate correlation is due to a difference in the HeMo and PPG APW contours. 
This is likely due to a variety of factors, however, primary among them are the different 
recording locations and sensor types. HeMo APWs are recordings of changes in limb blood 
volume due to the pulse passing through all vessels in the recording region, whereas the PPG 
APW is a localised recording at the big toe. The difference in the size/lumen of the arterial 
vessels in these regions can affect the shape of arterial pulse [239]. Furthermore, as HeMo is 
a summation of all arterial flow in the area, whereas PPG is highly specific to one region, any 
difference in arterial flow in adjacent vessels in the measurement region of HeMo will lead to 
temporal dispersion and flattening of the compound signal. The difference seen in the 
contours of PPG and HeMo may be partially explained by the wave steepening effect, a 
steepening of arterial pulse and decreasing in mean pressure with distance from the heart 
[229,240,241]. In other words, the shape of arterial pulse recordings at two different points of 
body would have looked differently even if they were both recording using the same type of 
sensor. Further discrepancies may be expected, as the PPG is an optical sensor while HeMo is 
mechanical, incorporating electro-resistive sensors. 
The statistically significant difference found in the APW features of HeMo and PPG does not 
undermine the potential of HeMo in diagnosing of PAD. It does highlight that APW features 
may not be used interchangeably. This indicates that if HeMo is to be used to diagnose PAD, 
its location is important and reference values will need to be calculated as thresholds for 
diagnosis.  
This comparison allowed us to explore the APW features of HeMo and understand how each 
APW feature of HeMo differs from PPG arterial pulse features. The damped shape and 
higher diastolic amplitude seen in the arterial pulse of HeMo resulted in higher values for 
most of the extracted HeMo APW features, except for stiffness index, which was lower than 
PPG. It should be noted that the half pulse width values for HeMo cluster in two groups.  In 
other words, there seems to be a considerable jump in half pulse width values. This effect 
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could be explained by the shape of the HeMo APW in which the dicrotic notch mainly occurs 
at a height close to the half-height of the pulse (Figure 5.13). Therefore, the pulse width 
values can be divided into two groups; one with smaller values corresponding to the pulses 
with their dicrotic notch occurring at half height or lower, and the other with higher half pulse 
width values corresponding to pulses which their dicrotic notch occurs at an amplitude 
greater than the half-height.  The dicrotic notch typically occurred below the half-height of 
PPG arterial pulses, resulting in a more homogenous dataset for PPG half pulse width. 
However, some of PPG arterial pulses also appeared with their dicrotic notch occurring at or 
above the half-height of the pulse. This observed discrepancy makes half pulse width an 
unsuitable metric in defining a range for normal and PAD subjects. To address this issue, we 
defined three quarters pulse width, which in contrast is a more homogenous feature. This is 
because the three quarters height is virtually guaranteed to be greater than the amplitude at 
which the dicrotic notch typically occurs. Although this alternative metric was found to 
provide a more homogenous dataset for HeMo, future clinical trials will be required to 
identify the diagnostic value of this metric. 
It should be also mentioned that among the extracted features rise time is the only APW 
feature which has been used to distinguish limbs with and without PAD [52]. A 95% 
confidence interval of PPG rise time was previously reported for healthy control subject by 
Allen et al. (0.172 - 0.278 seconds) [52]. The PPG rise time 95% confidence interval was 
lower in our study (range). This may be due to our younger population group (age range: 18-
56) compared to the age range in Allen et al.’s study (age range: 40-85). HeMo rise time 
values lied within the reported range by Allen et al.’s study. 
None of the PPG APW features showed statistically significantly differences before and after 
exercise (5 minute walk). All HeMo APW features, except half pulse width and augmentation 
index, were not significant difference between before and after exercise.  Augmentation index 
is dependent on the amplitude of systolic and diastolic peaks. As cardiac output increases 
with exercise, peripheral resistance decreases due to vasodilatation of the exercised muscle 
resulting in a rise in systolic peak but the diastolic peak remains largely unchanged [242]. 
While before and after walk augmentation index values were found not significantly different 
for PPG, we found the effect of exercise evident on HeMo augmentation index values. This 
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may be due to the location of HeMo, around the calf muscles. In contrast, PPG measures are 
localised underneath the skin of the toe where there are no muscles.  
There are a number of limitations for the work presented in this chapter. We were not able to 
make any statement about the agreement between the APW features of the two sensors due to 
lack of priori defined clinical limit criteria for the extracted features. We also were not able to 
provide a comparison between the systolic amplitude of HeMo and PPG due to their different 
measurement units. Among the extracted features only half pulse width and rise time have 
been shown to correlate with vascular resistance and the clinical value of other extracted 
features is not yet known for PAD. There is clearly a repeatability issue for HeMo that could 
be improved, potentially by averaging more pulse waves. Another limitation of the presented 
study is that the reference method is not the gold standard for diagnosis of PAD. The 
presented study only provides the comparison of APW features of HeMo and PPG in a group 
of healthy volunteers and does not include patients in the study population. A clinical trial 
with patients diagnosed with PAD and age-matched controls is required to have a better 
understanding of its APW features, to define threshold values for each, and to investigate the 
diagnostic value of each feature. 
Overall, this study highlights the potential of HeMo for low-cost and simplified diagnosis of 
PAD. However, an extensive clinical trial will be required to assess the legitimacy of this 
hypothesis. While the available diagnostic methods are expensive and usually reserved for 
patients with symptoms, HeMo is wearable, low-cost and requires minimal time and training, 
which may potentially lead to its widespread use as a screening tool for the assessment of 
arterial function in the leg.  
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Chapter 6 Discussion and Future Directions 
This chapter provides a summary of the work presented in this thesis by briefly discussing the 
motivation, objectives and achievements of the presented work. It is followed by a list of 




6.1 Summary of Contributions 
Despite the ubiquity of peripheral vascular disease (PVD) and the importance of early 
diagnosis, the available diagnostic methods do not completely meet the need of clinicians for 
diagnosis in the primary care setting. The need for a new non-invasive diagnostic device was 
the motivation for the work presented in this thesis. The development of a new medical 
device requires extensive verification and validation as a key element of the design process. 
A complete set of user needs is a base requirement to complete this process. This thesis does 
not attempt to complete this process, but assesses the possibility of a new non-invasive blood-
monitoring device and investigates a series of hypotheses to test a proof of concept device. 
This thesis demonstrates that HeMo can reliably capture arterial pulse wave and measure 
venous refilling time. HeMo was compared with LRR in a well-powered group of healthy 
volunteers and an acceptable agreement between the two devices was found suggesting that 
HeMo has good potential for assessing venous competence in the leg. It was found that 
HeMo needs improvements in terms of its reliability when is used for VFT measurement. 
Comparison of arterial pulse wave recordings from HeMo and PPG revealed information on 
the APW features of HeMo and helped to understand how each APW feature of HeMo differs 
from PPG arterial pulse features. This thesis also revealed information on the characteristics 
of the ERB sensors used in HeMo. Investigation of the electrical behaviour of the ERB 
sensors showed that the peak-to-peak voltage of ERB sensors is associated with a drift during 
the first 40 hours of use, which then stabilises. Combined, these findings feed into the design 
requirements and user needs for the next stage of development in the commercialisation 
process. The main outcomes of the presented work include: 
1. A comprehensive literature review of the available non-invasive diagnostic methods 
for PVDs was given discussing the advantages and limitations of each method. This 
review further highlights the need for new diagnostic tools and justifies the overall 
aim of the thesis. 
 
2. HeMo was introduced as a candidate for hemodynamic monitoring and a simplified 
version of its embodiment and circuitry is presented. Pilot proof-of-concept 
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recordings demonstrate the potential to measure the arterial pulse wave and venous 
filling time. These experiments show that HeMo may be useful for the diagnosis of 
both arterial disease and chronic venous insufficiency. 
 
3. A simulator rig was introduced and used to compare data from electro-resistive bands 
sensor and a linear displacement sensor during their simultaneous 
expansions/contractions. The comparison of the data from the two sensors provided 
characterisation of the electrical behaviour of the electro-resistive band sensors. 
HeMo incorporates electro-resistive bands to sense the changes in blood flow. 
Therefore, the characterisation of the ERB sensors was necessary to provide an 
understanding of the nonlinear behaviour of the sensor. Of note, the presented 
characterisation may be of interest for other applications/users of this sensor.  
 
4. Venous filling measurements from HeMo were compared with measurements from an 
established medical device, a light reflection rheography sensor, in a group of thirty-
six healthy volunteers. The VFT measurements of both HeMo and LRR exhibited 
issues with repeatability. As the VFT measurement experiment is quite short the 
repeatability issue could potentially be ameliorated by taking the average of multiple 
measures as we have done. Both HeMo and LRR VFT measurements were further 
affected by inter-rater reliability problems, highlighting the need for an automated 
computer framework for the selection of the start and end of venous refilling. Overall, 
the comparison showed an agreement between the VFT measurements of the two 
sensors, with all subjects classified as healthy further demonstrating the potential of 
HeMo for diagnosis of CVI. Additionally, HeMo was more robust to exercise 
compared to LRR, which could lead to a reduction in examination time. Finally, this 
work provides a control healthy patient dataset that may be of use in future research 
as a comparator to clinical data. 
 
5. Arterial pulse wave recordings from HeMo were compared with simultaneous 
recordings from an established medical photoplethysmography sensor, in a group of 
thirty-six healthy volunteers. Eight arterial pulse wave features were extracted from 
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HeMo and PPG and they were statistically compared. A repeatability problem was 
associated with HeMo APW features, which could be ameliorated by taking the 
average multiple APW epochs. We found the broader shape of HeMo APW’s to be 
responsible for the differences seen between APW features of HeMo and PPG. This 
comparison revealed the differences of HeMo arterial recordings compared to PPG 
pulse recordings, generating a better understanding of the HeMo arterial pulse wave 
and its features. This comparison also highlighted that the location of APW recording 
is important. We discovered that HeMo half pulse width values are clustering in two 
groups, which could be problematic for the diagnosis of PAD. This problem also 
existed in PPG recordings, albeit less frequently. We introduced an alternative feature, 
three quarters pulse width, which generated homogenous values. However, the 
diagnostic value of this metric needs to be investigated in clinical trials. We also 
found HeMo capable of sensing peripheral resistance changes with exercise, as the 
effect of exercise was evident in the HeMo augmentation index values. Overall, 
HeMo and PPG arterial pulse recordings agreed in term of their overall shape and 
visualising the dicrotic notch, highlighting the potential of HeMo for diagnosis of 
PAD. 
Overall, the work presented in thesis is a step towards the development and validation of new 
non-invasive monitoring device, which can provide information about arterial and venous 
function in less time, with less training and at a lower cost compared to the available 




6.2 Future Directions 
There are a number of points, which should be considered in future extension of the presented 
thesis: 
1. The electro-resistive band sensors used in HeMo were sensitive enough to capture 
both the blood volume variations due to arterial inflow and postural changes. 
However, testing other stretchable sensors is recommended as this would lead to 
replace the exploited ERBs with a sensor with better precision, which would lead to 
have more repeatable VFT measurements/APW features. Of course, replacement of 
the ERBs will require characterisation of the electrical behaviour of the newly 
replaced sensor and it also may need modification of HeMo circuit.  
 
2. Future research should examine the performance of HeMo in a clinical setting. Of 
note, data recorded from patients may require modification of HeMo. For example, 
disposable stretchable material may be needed to prevent infection. HeMo would also 
need to become adjustable in size to fit patients with larger legs. Additionally, the 
current design of HeMo is not suited for patients with active wounds or leg injury. 
HeMo could be modified such that the wound area is unaffected. Multiple design 
options could be explored. For example, a single ERB could be used on a narrow 
piece of stretchable fabric, which could be placed above or below the wound. Another 
solution could include two or more ERB sensors placed on wound-free sites on the 
lower leg.  
A clinical trial of HeMo would identify whether the HeMo VFT measurements/APW 
features are accurate in diagnosing venous disease, arterial disease and the presence of 
both. The comparison of control and patient data would enable the definition of 
optimum thresholds for VFT and each of the APW features. Moreover, the clinical 
value of each HeMo APW features could be investigated. This investigation may lead 
to find the best feature or combination of features for the discrimination of legs with 
and without PAD.  
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Future research should also determine the bilateral difference for VFT 
measurements/APW features using HeMo. This is important as diagnostic information 
about peripheral circulation can be inferred from the loss of similarity in the 
measurements of sides and the degree of asymmetry can represent the severity of 
disease [52]. Additionally, measurements of bilateral differences have been shown 
better repeatability compared to measurements from single sides [52,241].  
Although light reflection rheography and photoplethysmography are not the gold 
standards for diagnosis of chronic venous insufficiency and peripheral arterial disease, 
they were chosen as the comparator tools in the presented work in this thesis. Duplex 
ultrasound is the gold standard, but is expensive and requires clinical experts and so 
we could not use this for this preliminary development.  The next stage of 
development will require assessing HeMo use with patients diagnoses with peripheral 
vascular diseases, recruited from a clinic with clinicians performing ABI, TBI, and 
duplex ultrasound tests, comparing all these with HeMo. Of course, the comparison of 
HeMo measurements with the gold standard will be required to identify the 
sensitivity, specificity and accuracy of HeMo, and ultimately validate HeMo as a 
screening tool for diagnosis of PAD and CVI.  
3. A variety of features can be extracted from both the arterial pulse recording and its 
first and second derivatives, which may have diagnostic value for other clinical 
applications. For example, pulse width/pulse interval have been shown to be useful 
for the monitoring of heart rate variability [48]. Augmentation index, stiffness index, 
and a number of features from the first and second derivatives of APW have been 
shown to detect arterial stiffness/distensibility [48]. Future research should further 
develop and confirm these findings for HeMo APW features, which would potentially 
lead to use of HeMo for convenient heart rate variability monitoring and diagnosis of 
arterial stiffness. 
 
4. Future research is required to investigate the capability of HeMo for detection of deep 
vein thrombosis, which is another common type of PVDs with fatal complications. 
Diagnosis of DVT is complicated as more than two third of patients of DVT do not 
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show any symptoms [242]. Additionally, while the early diagnosis is crucial, most of 
the available techniques are reserved for patients with symptoms. Several studies have 
shown the capability of LRR for detection of DVT [56,57,242]. These studies have 
shown that the slope of blood emptying during ten-dorsiflexion exercise can be used 
as marker to detect DVT. They classified LRR trace based on their slope and achieved 
sensitivity of 92%-96.4% and specificity of 82.9%-84% compared to venography 
[56,57,242]. In chapter 4, venous filling time were extracted from HeMo and LRR 
traces. It is evident that venous emptying slope of HeMo and LRR can be also 
extracted and compared. Comparison of the venous emptying slope of controls and 
patients can identify the clinical value of HeMo for detection of DVT.  
 
5. VFT values were measured from HeMo and LRR venous filling traces by annotating 
start and end of refilling. Of course, we now know that there is error associated with 
this method as we found discrepancy between the VFT values from three annotations. 
An automated framework instead could improve the repeatability and reliability of 
VFT measurements. However, no automatic algorithm for detection of the start and 
end points of VFT has been published to our knowledge. Of note the VasoScreen 
device does have a semi-automatic inbuilt algorithm to identify the start and end 
points. However, we found their algorithm requiring manual modification of the 
automatic selected points in many cases. Additionally, this algorithm has not been 
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Appendix A Graphical User Interfaces and User 
Guidelines 
A.1 User Guide for VFT Annotation 
• The Matlab script in section A.3 is named VFT_Measurement.m. 
 
• Run VFT_Measurement.m and the GUI will open as shown in Figure A.1: 
 
 
Figure A.1. VFT annotation GUI opened. A cursor is available for selecting the start point of refilling. 
 
• As can be seen in Figure A.2, once you run the GUI you can select the start of 




• Once the start point of refilling is selected, a cursor will appear again to allow 
selection of the end point of refilling. The endpoint is where the recording reaches a 
stable baseline [45,51,59,87,193,243]. 
•  
 
Figure A.2. VFT annotation GUI opened. The start point is shown in blue cross. A cursor is available 
for selecting the end point of refilling. 
 
 
• Once both the start and end points are selected (Figure A.3), if you are happy with 
what you have chosen you can click on save and continue to save what you annotated 
and continue annotating the rest of the data. 
 
• In the bottom panel of the GUI (Figure A.3), you can see the calculated venous 
filling time measured based on your chosen points.  
 
• You can also see how many data are remaining to be annotated. 
 
• If you are not happy with what you have annotated (e.g. you marked the start point or 
the endpoint in a wrong place by mistake), finish annotation for the current data (e.g. 
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you annotated the start point by mistake, just choose an endpoint to finish the 
annotation). You then can click on the clear button to clear your previous annotation 




Figure A.3. VFT annotation GUI opened. The start and end points are shown in blue crosses. The VFT 
measurement is shown in the bottom panel. 
 
 
• Once the data annotation is completed the GUI window can be closed, and all 
information will be automatically saved as LRR_VFT_DB.mat in the folder where 
the VFT_Measurement.m file is saved.  
 
• The GUI window can be closed before completing annotation of all the data. In this 
case, with the re-run of the GUI, the annotation will resume from where it stopped. 
 




















A.2 User Guide for APW Annotation 
• The presented Matlab script in section A.4 is named APW_Measurement.m. 
 
• Run APW_Measurement.m and you will see the GUI will show up as in Figure A.6. 
 
• As can be seen in Figure A.6, once you run the GUI, two plots will appear. The top 
plot is the arterial pulse wave and the bottom one is its second derivative. A cursor 




Figure A.6. APW GUI.  
 
• Five points should be selected for each epoch of data. These points include the start 
point of the arterial pulse, the systolic peak, the dicrotic notch, the diastolic peak and 




• Each of the point can be selected either from the top panel or the bottom panel and the 
marked point on the other panel will be shown automatically. However, it would be 
easier to select the start point, systolic peak, diastolic peak and the end point using the 
top panel. As a local maximum appears on the second derivative signal at where the 
dicrotic notch occurs, using the second derivative will help to annotate the dicrotic 
notch. 
 
• The start point can be selected by clicking on the point where you think the arterial 
pulse wave starts. 
 
• Once the start point is selected, a cursor will appear again to allow marking of the 
systolic peak. The systolic peak is shown in Figure A.7. 
 
• Once the systolic peak is selected, a cursor will appear again to allow marking of the 
dicrotic notch. The dicrotic notch is shown in Figure A.7. 
 
• Once the dicrotic notch is selected, a cursor will appear again to allow marking of the 
diastolic peak. The diastolic peak is shown in Figure A.7. 
 
• Finally, once the diastolic peak is selected, a cursor will appear again to allow 






Figure A.7. Illustration of arterial pulse wave and its second derivative. Panel (a) shows the arterial pulse; Panel 
(b) shows the second derivative of the arterial pulse. 
 
• Once the five points are selected (Figure A.8), if you are happy with what you have 
chosen you can select the “save and continue” button to save what you have annotated 
and continue annotating the rest of the data. 
 
• There is a checkbox panel on the top right side of the GUI, which will show the order 
of the points you need to annotate. Each check box will be checked as you select 
points (Figure A.8). 
 
• On the right panel, you can also see how many epochs remain to be annotated. 
 
• If you are not happy with any epochs that you have annotated (e.g. you marked any of 
the of the five points in a wrong place by mistake), finish annotation for the current 
data (e.g. you annotated the start point by mistake, just choose rest of the points to 
finish the annotation) and then you can click on the clear button to clear your previous 






Figure A.8. APW GUI opened. User selected starting point, systolic peak, dicrotic 
notch, diastolic peak and end point are marked with blue, purple, black, red and yellow crosses. 
 
 
• Once the data annotation is complete, all information will be automatically saved as 
APW_DB.mat in the same folder where the APW GUI is saved.  
 
• The GUI window can be closed before completing annotation of all data. In this case, 
when the GUI is reopened, the annotation will resume from the data at which the 
annotation was stopped. 
 
















A.3 Venous Filling Time Annotation Graphical User Interface 
function varargout = VFT_Measurement(varargin) 
% VFT_MEASUREMENT MATLAB code for VFT_Measurement.fig 
%      VFT_MEASUREMENT, by itself, creates a new VFT_MEASUREMENT or raises 
the existing 
%      singleton*. 
% 
%      H = VFT_MEASUREMENT returns the handle to a new VFT_MEASUREMENT or 
the handle to 
%      the existing singleton*. 
% 
%      VFT_MEASUREMENT('CALLBACK',hObject,eventData,handles,...) calls the 
local 
%      function named CALLBACK in VFT_MEASUREMENT.M with the given input 
arguments. 
% 
%      VFT_MEASUREMENT('Property','Value',...) creates a new 
VFT_MEASUREMENT or raises the 
%      existing singleton*.  Starting from the left, property value pairs 
are 
%      applied to the GUI before VFT_Measurement_OpeningFcn gets called.  
An 
%      unrecognized property name or invalid value makes property 
application 
%      stop.  All inputs are passed to VFT_Measurement_OpeningFcn via 
varargin. 
% 
%      *See GUI Options on GUIDE's Tools menu.  Choose "GUI allows only one 
%      instance to run (singleton)". 
% 
% See also: GUIDE, GUIDATA, GUIHANDLES 
  
% Edit the above text to modify the response to help VFT_Measurement 
  
% Last Modified by GUIDE v2.5 03-Mar-2018 22:36:07 
  
% Begin initialization code - DO NOT EDIT 
gui_Singleton = 1; 
gui_State = struct('gui_Name',       mfilename, ... 
                   'gui_Singleton',  gui_Singleton, ... 
                   'gui_OpeningFcn', @VFT_Measurement_OpeningFcn, ... 
                   'gui_OutputFcn',  @VFT_Measurement_OutputFcn, ... 
                   'gui_LayoutFcn',  [] , ... 
                   'gui_Callback',   []); 
if nargin && ischar(varargin{1}) 




    [varargout{1:nargout}] = gui_mainfcn(gui_State, varargin{:}); 
else 
    gui_mainfcn(gui_State, varargin{:}); 
end 





% --- Executes just before VFT_Measurement is made visible. 
function VFT_Measurement_OpeningFcn(hObject, eventdata, handles, varargin) 
% This function has no output args, see OutputFcn. 
% hObject    handle to figure 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
% varargin   command line arguments to VFT_Measurement (see VARARGIN) 
global Images index FileName PathName Hemo point; 
  
  
% Choose default command line output for VFT_Measurement 
handles.output = hObject; 
  
% Update handles structure 
guidata(hObject, handles); 
  













% --- Outputs from this function are returned to the command line. 
function varargout = VFT_Measurement_OutputFcn(hObject, eventdata, handles)  
% varargout  cell array for returning output args (see VARARGOUT); 
% hObject    handle to figure 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
  
% Get default command line output from handles structure 
varargout{1} = handles.output; 
  
% --- Executes on button press in setpoint. 
function setpoint(handles) 
% handles    structure with handles and user data (see GUIDATA) 
  



























% --- Executes on button press in next. 
function next_Callback(hObject, eventdata, handles) 
% hObject    handle to next (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 




    index=index+1; 
    plot_data(handles); 
   
    set(handles.edit3,'string',num2str(index)); 
    setpoint(handles) 
    save([PathName,'/',FileName],'point','index','-append'); 




% --- Executes on button press in clear. 
function clear_Callback(hObject, eventdata, handles) 
% hObject    handle to clear (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 






% --- Executes during object creation, after setting all properties. 
function edit1_CreateFcn(hObject, eventdata, handles) 
% hObject    handle to edit1 (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    empty - handles not created until after all CreateFcns called 
  
% Hint: edit controls usually have a white background on Windows. 
%       See ISPC and COMPUTER. 
if ispc && isequal(get(hObject,'BackgroundColor'), 
get(0,'defaultUicontrolBackgroundColor')) 




















    plot(Hemo(index-length(Images)).Time,Hemo(index-length(Images)).Data) 




% --- Executes during object creation, after setting all properties. 
function edit3_CreateFcn(hObject, eventdata, handles) 
% hObject    handle to edit3 (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    empty - handles not created until after all CreateFcns called 
  
% Hint: edit controls usually have a white background on Windows. 
%       See ISPC and COMPUTER. 
if ispc && isequal(get(hObject,'BackgroundColor'), 
get(0,'defaultUicontrolBackgroundColor')) 





% --- Executes during object creation, after setting all properties. 
function edit4_CreateFcn(hObject, eventdata, handles) 
% hObject    handle to edit4 (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    empty - handles not created until after all CreateFcns called 
  
% Hint: edit controls usually have a white background on Windows. 
%       See ISPC and COMPUTER. 
if ispc && isequal(get(hObject,'BackgroundColor'), 
get(0,'defaultUicontrolBackgroundColor')) 





A.4 Arterial Pulse Wave Annotation Graphic User Interface 
function varargout = APW_annotation(varargin) 
% APW_annotation MATLAB code for APW_annotation.fig 
%      APW_annotation, by itself, creates a new APW_annotation or raises 
the existing 
%      singleton*. 
% 
%      H = APW_annotation returns the handle to a new APW_annotation or the 
handle to 
%      the existing singleton*. 
% 
%      APW_annotation('CALLBACK',hObject,eventData,handles,...) calls the 
local 
%      function named CALLBACK in APW_annotation.M with the given input 
arguments. 
% 
%      APW_annotation('Property','Value',...) creates a new APW_annotation 
or raises the 
%      existing singleton*.  Starting from the left, property value pairs 
are 
%      applied to the GUI before APW_annotation_OpeningFcn gets called.  An 
%      unrecognized property name or invalid value makes property 
application 
%      stop.  All inputs are passed to APW_annotation_OpeningFcn via 
varargin. 
% 
%      *See GUI Options on GUIDE's Tools menu.  Choose "GUI allows only one 
%      instance to run (singleton)". 
% 
% See also: GUIDE, GUIDATA, GUIHANDLES 
  
% Edit the above text to modify the response to help APW_annotation 
  
% Last Modified by GUIDE v2.5 02-Jul-2018 10:25:16 
  
% Begin initialization code - DO NOT EDIT 
gui_Singleton = 1; 
gui_State = struct('gui_Name',       mfilename, ... 
                   'gui_Singleton',  gui_Singleton, ... 
                   'gui_OpeningFcn', @APW_annotation_OpeningFcn, ... 
                   'gui_OutputFcn',  @APW_annotation_OutputFcn, ... 
                   'gui_LayoutFcn',  [] , ... 
                   'gui_Callback',   []); 
if nargin && ischar(varargin{1}) 




    [varargout{1:nargout}] = gui_mainfcn(gui_State, varargin{:}); 
else 
    gui_mainfcn(gui_State, varargin{:}); 
end 





% --- Executes just before APW_annotation is made visible. 
function APW_annotation_OpeningFcn(hObject, eventdata, handles, varargin) 
% This function has no output args, see OutputFcn. 
% hObject    handle to figure 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
% varargin   command line arguments to APW_annotation (see VARARGIN) 
global Hemo_list index FileName PathName PPG_list point counter CASE ; 
  
  
% Choose default command line output for APW_annotation 
handles.output = hObject; 
  













% --- Outputs from this function are returned to the command line. 
function varargout = APW_annotation_OutputFcn(hObject, eventdata, handles)  
% varargout  cell array for returning output args (see VARARGOUT); 
% hObject    handle to figure 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
  
% Get default command line output from handles structure 
varargout{1} = handles.output; 
  
% --- Executes on button press in setpoint. 
function setpoint(handles) 
% handles    structure with handles and user data (see GUIDATA) 
  
global point index  CASE TIME DATA DATA_2driv 
  























































































% --- Executes on button press in next. 
function next_Callback(hObject, eventdata, handles) 
% hObject    handle to next (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 









    counter=counter+1; 
    CASE=CASE+1; 
  
if CASE>3 
    CASE=1; 
    index=index+1; 
end 
  save([PathName,'/',FileName],'point','index','counter','CASE','-append'); 
  
if counter<=(length(PPG_list)+length(Hemo_list))*3 
    plot_data(handles); 
    set(handles.edit3,'string',num2str(counter)); 
    setpoint(handles) 
end    
end 
  
% --- Executes on button press in clear. 
function clear_Callback(hObject, eventdata, handles) 
% hObject    handle to clear (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 














% --- Executes during object creation, after setting all properties. 
function edit1_CreateFcn(hObject, eventdata, handles) 
% hObject    handle to edit1 (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    empty - handles not created until after all CreateFcns called 
  
% Hint: edit controls usually have a white background on Windows. 
%       See ISPC and COMPUTER. 
if ispc && isequal(get(hObject,'BackgroundColor'), 
get(0,'defaultUicontrolBackgroundColor')) 








global index PPG_list Hemo_list CASE TIME DATA DATA_2driv 
% if index>length(PPG_list)+length(Hemo_list)  




     
switch CASE 
    case 1 
        TIME=PPG_list(index).Time1; 
        DATA=PPG_list(index).Data1; 
        
    case 2 
        TIME=PPG_list(index).Time2; 
        DATA=PPG_list(index).Data2; 
        
    case 3 
       TIME=PPG_list(index).Time3; 










  grid on 
   
else 
    switch CASE 
    case 1 
        TIME=Hemo_list(index-length(PPG_list)).Time1; 
        DATA=Hemo_list(index-length(PPG_list)).Data1; 
    case 2 
        TIME=Hemo_list(index-length(PPG_list)).Time2; 
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        DATA=Hemo_list(index-length(PPG_list)).Data2; 
  
    case 3 
        TIME=Hemo_list(index-length(PPG_list)).Time3; 
        DATA=Hemo_list(index-length(PPG_list)).Data3; 
  
    end 
  axes(handles.axes4) 
  DATA_2driv=diff(diff(DATA)); 
  plot(TIME(1:end-2),DATA_2driv); 
  yl=ylim(handles.axes4); 
  axis(handles.axes4,'tight') 
  ylim(handles.axes4,yl) 
  grid on 







 grid on 
 
% --- Executes during object creation, after setting all properties. 
 function edit3_CreateFcn(hObject, eventdata, handles) 
% hObject    handle to edit3 (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    empty - handles not created until after all CreateFcns called 
  
% Hint: edit controls usually have a white background on Windows. 
%       See ISPC and COMPUTER. 
if ispc && isequal(get(hObject,'BackgroundColor'), 
get(0,'defaultUicontrolBackgroundColor')) 




% --- Executes during object creation, after setting all properties. 
function edit4_CreateFcn(hObject, eventdata, handles) 
% hObject    handle to edit4 (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    empty - handles not created until after all CreateFcns called 
  
% Hint: edit controls usually have a white background on Windows. 
%       See ISPC and COMPUTER. 
if ispc && isequal(get(hObject,'BackgroundColor'), 
get(0,'defaultUicontrolBackgroundColor')) 
    set(hObject,'BackgroundColor','white'); 
end 
   
